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Abstract
The iAAA protease is an ATP-dependent proteolytic complex
in the mitochondrial inner membrane and belongs to the highly
conserved family of AAA proteins. In the yeast Saccharomyces cere-
visiae, the iAAA protease is a homo-oligomeric complex composed
of Yme1p subunits which are active in the intermembrane space and
mediate protein quality control. Yeast cells lacking Yme1p are charac-
terized by pleiotropic phenotypes including a respiratory deficiency
at elevated temperature and an aberrant mitochondrial morphology.
However, the molecular basis of the different yeast yme1 phenotypes
has not been completely understood. Human YME1L was shown to
be the ortholog of the yeast Yme1p, but its functions within mam-
malian mitochondria and specific substrate proteins have not been
identified so far. In order to define the roles of the mammalian iAAA
protease two main approaches were carried out: (1) down regulation
studies in mammalian cells using RNA interference, and (2) inducible
overexpression of YME1L and several mutant variants in the mam-
malian system.
The present study reports the functional conservation of the mam-
malian YME1L by showing its involvement in the proteolysis of pro-
hibitin 1 whose homolog is also degraded by the iAAA protease in
yeast. Furthermore, it demonstrates that YME1L has a role in the
maintenance of the tubular mitochondrial morphology and in the
constitutive processing of OPA1, a component of the mitochondrial
fusion machinery. Moreover, the degradation of TIM23, a core sub-
unit of the translocase of the inner membrane, in caspase-independent
apoptosis depends on YME1L identifying a novel substrate for the
mammalian iAAA protease and a new pathway it is involved in. The
overexpression of YME1L mutants has no dominant negative effect
on the iAAA protease. Its functions in mitochondrial proteolysis, im-
port, and mitochondrial morphology remain unaltered.
Taken together, this study reveals versatile roles of mammalian
YME1L in proteolytic quality control, mitochondrial morphology
II
and apoptosis, thus demonstrating its importance for both the cel-
lular viability and death.
III
Zusammenfassung
Die iAAA-Protease ist ein ATP-abhängiger proteolytischer Kom-
plex in der inneren Mitochondrienmembran und gehört zu der hoch-
konservierten Familie der AAA-Proteine. In der Hefe Saccharomyces
cerevisiae ist die iAAA-Protease ein homooligomerer Komplex beste-
hend aus Yme1p-Untereinheiten, die im Intermembranraum aktiv
sind und die Qualitätskontrolle von Proteinen vermitteln. Hefezel-
len, denen Yme1p fehlt, sind durch pleiotrope Phänotypen charak-
terisiert. Diese beinhalten einen Atmungsdefekt bei erhöhter Tempe-
ratur und eine gestörte mitochondriale Morphologie. Jedoch ist die
molekulare Grundlage der verschiedenen yme1-Phänotypen in Hefe
bisher nicht vollständig verstanden. Das humane YME1L wurde als
Ortholog von Yme1p der Hefe beschrieben, aber seine Funktionen
in Säugetier-Mitochondrien und spezifische Substratproteine sind
noch nicht identifiziert worden. Um die Rolle der iAAA-Protease
in Säugetieren zu bestimmen, wurden zwei experimentelle Ansät-
ze verfolgt: (1) Depletion von YME1L in Säugetier-Zellen mittels
RNA-Interferenz und (2) induzierbare Überexpression von YME1L
und verschiedenen mutierten Varianten im Säugetier-System.
Die vorliegende Arbeit demonstriert die funktionelle Konservie-
rung von YME1L in Säugetieren, indem gezeigt wird, dass es an
der Proteolyse von Prohibitin 1 beteiligt ist, dessen Homolog in
der Hefe ebenfalls von der iAAA-Protease abgebaut wird. Deswei-
teren, weist sie nach, dass YME1L eine Rolle bei der Aufrechter-
haltung der tubulären mitochondrialen Morphologie und bei der
konstitutiven Prozessierung von OPA1, einem Bestandteil der mit-
ochondrialen Fusionsmaschinerie, spielt. Darüber hinaus ist der Ab-
bau von Tim23, einer Kernuntereinheit der Translocase in der In-
nenmembran, während der caspaseunabhängigen Apoptose abhän-
gig von YME1L. Dieser Befund identifiziert ein neues Substrat der
iAAA-Protease in Säugetieren und einen neuen zellulären Prozess,
an dem sie beteiligt ist. Die Überexpression von YME1L-Mutanten
hat keinen dominant-negativen Einfluss auf die iAAA-Protease. Ihre
IV
Funktionen in mitochondrialer Proteolyse, Morphologie und Import
bleiben unverändert.
Zusammengefasst offenbart diese Arbeit vielfältige Rollen von
YME1L bei der Qualitätskontrolle von Proteinen, der mitochondria-
len Morphologie und der Apoptose in Säugetieren und demonstriert
somit die Bedeutung von YME1L für sowohl die zelluläre Lebensfä-
higkeit als auch den zellulären Tod.
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Chapter 1
Introduction
The mitochondrion is a complex organelle that possesses a multitude
of functions, some of which are essential for the cellular survival. Beside
its role in respiration and energy supply, it is involved in the apoptotic
signaling, aging, synthesis of metabolites, lipid metabolism free radical
production, metal ion homeostasis and the assembly of iron-sulfur (Fe-S)
clusters. The latter are present in more than 120 distinct types of enzymes
and proteins having function in the electron transfer, substrate binding,
regulation of gene expression and enzyme activity [38]. Interestingly, syn-
thesis of Fe-S clusters is the sole function maintained in so called “relict
mitochondria” present in amitochondriate protists like Giardia, [156] sug-
gesting that this function is the basis for the evolutionarily essential nature
of mitochondria.
It is widely accepted that a mitochondrion has a monophyletic origin
from an α - proteobacterial ancestor being an endosymbiont of eukaryotic
cells, and as such it has following special features: first, it can be only in-
herited by the daughter cells, not synthesized de novo; second, it possesses
its own genome and transcription and translation apparatus; and third,
it is dividing and fusing. During the evolution from α - proteobacteria to
eukaryotic organelle, many bacterial genes were transferred into the nu-
clear genome of eukaryotic cells [68]. As a consequence, targeting signals
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on the nuclear encoded polypeptides as well as translocation machineries
in both outer and inner membrane developed. An estimate is that the mi-
tochondrial proteome contains around 1000 proteins [136; 151] but only 3
to 32 are mitochondrially encoded [60] depending on the organism. Those
genes that resisted transfer to the nucleus encode mainly proteins inca-
pable of translocation from the cytosol into the mitochondrion, for exam-
ple extremely hydrophobic proteins like subunits of cytochrome c oxidase
or hydrophobic segments of cytochrome b. The proportion of hydrophilic
proteins encoded by the mitochondrial genome declined with decreasing
genome complexity, but the necessity to synthesize highly hydrophobic
ones in the mitochondrial matrix was probably the force that made the
eukaryotic cells keep mitochondrial DNA (mtDNA).
Proteins encoded in the nuclear genome and synthesized in the cytosol
are imported into one of four mitochondrial locations [42]: (1) the outer
membrane (OM), (2) the intermembrane space (IMS), (3) the inner mem-
brane (IM), and (4) the matrix (M).
Translocation through the outer membrane is performed by TOM com-
plex. Outer membrane proteins contain targeting information within and
near the transmembrane domain [85]. Insertion into the inner mitochon-
drial membrane proceeds in at least three different ways: (1) through the
TIM23 complex and lateral insertion into the lipid bilayer; (2) through the
TIM22 complex, and (3) translocation through the inner membrane pro-
tein Oxa1, which belongs to a highly conserved protein family present in
mitochondria, bacteria and chloroplasts [173]. Proteins translocated in this
pathway carry presequences and are completely imported into the ma-
trix and further into the inner membrane. Matrix proteins are translocated
across the inner membrane by TIM23 complex in an ATP- and transmem-
brane potential - dependent manner, where their presequences are pro-
cessed and folding follows.
The outer mitochondrial membrane forms an envelope and presents a
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barrier only for macromolecules as it contains pore forming proteins that
allow the free passage of solutes up to few thousands Dalton in size [161].
Inner mitochondrial membrane encloses the matrix space. Even ions
and metabolic substrates cannot pass it without the help of carrier pro-
teins. It is the membrane, where multisubunit protein complexes reside,
fulfilling various mitochondrial functions, like: oxidative phosphorylation
(OXPHOS), translocation, metabolic exchange, protein assembly, Fe-S bio-
genesis and proteolytic degradation [161]. The inner membrane is orga-
nized in two morphologically distinct domains: (1) the inner boundary
membrane, which is a second envelope, forms contact sites with the outer
membrane and functionally interacts with it, and (2) cristae membrane,
building up inner membrane invaginations connected to the boundary in-
ner membrane through ring-shaped cristae junctions.
Mitochondrial cristae undergo morphological changes in response to
changing metabolic requirements and/or matrix volume. An exchange of
the inside content with the rest of intermembrane space was connected to
metabolic and apoptotic pathways [81; 102].
1.1 Mitochondrial dynamics
Mitochondria form an interconnected tubular network, whose steady
state morphology is a derivative of three different processes: First, fusion
and fission which control mitochondrial shape and size; second, active
transport inside a cell, controlling subcellular distribution of mitochon-
dria; third, metabolic status of the mitochondrion itself. The balance be-
tween fusion and fission regulates mitochondrial morphology, i.e. shape,
length and number, which affects the ability of cells to distribute the mito-
chondria to specific subcellular locations. Fusion and fission also allow ex-
change of membrane lipids as well as mitochondrial content mixing. Such
a dynamic behavior is crucial for a number of cellular processes, such as
apoptosis, the inheritance of mtDNA, defense against oxidative stress, and
3
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development through spermatogenesis [26; 30; 65]. It provides one of the
ways for the quality control allowing constant mixing of potentially dam-
aged mitochondria with healthy ones [147]. Hence, mitochondrial dynam-
ics plays and important role in both cellular survival and death [73].
Mitochondrial fusion and fission are unique in two main aspects: first,
because of double membrane boundary, they have to proceed in a strictly
coordinated way to ensure integrity of both membranes plus two mito-
chondrial subcompartments: matrix and intermembrane space; and sec-
ond, there is no evidence for the involvement of SNARE proteins, having
function in other cellular fusion events.
In mammalian cells fission requires dynamin-related protein 1 (Drp1)
predominantly distributed in the cytosol and partially associated with the
mitochondrial outer membrane [137; 175] together with hFis1, an outer
membrane protein [142], endophilin B1/Bif1 [79], MTP18, GDAP1 and
DAP3 [167]. A portion of cytosolic Drp1 can be recruited to mitochondria
through an interaction with hFis1 [174].
Mitochondrial fission is counterbalanced by the fusion. Fzo1p was
shown to be required for fusion in Drosophila melanogaster [65] and yeast
[67]. Mammalian outer membrane proteins mitofusin 1 and mitofusin 2
are functional homologues of Fzo1p, involved in the mitochondrial fusion
[27; 125; 130]. Mitofusins form homo- and hetero - oligomeric complexes
and are required for adjacent mitochondria during the fusion process sug-
gesting formation of trans complexes of the apposing mitochondria [89].
Another protein - yeast Mgm1, a dynamin-related GTPase, is essential for
the mitochondrial inner membrane fusion, maintaining mtDNA and in-
ner membrane structures in yeast [105; 135; 172]. Yeast outer membrane
protein Ugo1 physically links Mgm1 and Fzo1, however no mammalian
homologue has been discovered so far [115]. It was reported that the mam-
malian homologue of Mgm1, OPA1, interacts physically with Mfn1/2 [64].
OPA1 is an IMS protein with soluble or closely associated with the
inner membrane pools. It is thought to form oligomers involved in the
4
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regulation of mitochondrial cristae morphology and complete release of
cytochrome c which is sequestered in the intra - cristae regions [9; 33; 51;
116]. OPA1 is a casual gene product of autosomal dominant optic atrophy
which features a progressive loss of retinal ganglion cells that leads to legal
blindness [4; 40].
In human cells there are eight splice variants of OPA1 each of which
is subsequently processed to form several isoforms with distinct molec-
ular sizes [41]. The combination of long and short OPA1 isoforms is im-
portant for mitochondrial fusion activity [138]. Processing of OPA1 is acti-
vated by the transmembrane potential dissipation [44] and strongly corre-
lates with stimulation of the mitochondrial fragmentation [73]. There have
been reports linking loss of OPA1 to defects in mitochondrial respiration,
increased release of cytochrome c [9] and susceptibility towards apopto-
sis [28; 92], as well as reduction of the mitochondrial transmembrane po-
tential [116]. They point to additional functions of OPA1, independent of
mitochondrial fusion. In yeast Mgm1 is required for oligomerization of
F1F0ATP synthase, an inner membrane enzyme coupling proton pumping
to ATP synthesis, essential for normal cristae structure [120]. This require-
ment provides a link between these two modulators of cristae structure
[5].
1.2 Apoptosis and a link between apoptosis and
a fusion/fission machinery
The development of cytokine - mediated apoptosis programs in higher
multicellular organisms provides a crucial way to coordinate the regula-
tion of cell numbers at the organism level in response to the environmental
stimuli [39]. In C.elegans and mice the most frequent form of developmen-
tal cell death is apoptosis [1; 34]. It can proceed in three main pathways
(summarized on Fig. 1.1): (1) intrinsic, (2) extrinsic, and (3) granzyme
B-mediated pathway. The most noticeable and characteristic features of
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Figure 1.1: Caspase activation pathways
Intrinsic pathway (1): BH3-only proteins are activated by the cell stress or damage and overcome the inhibitory
effect of BCL-2 family members. BAX-BAK assembly in the mitochondrial OM permit the efflux of intermem-
brane space proteins, like cytochrome c into the cytosol. Cytochrome c triggers the apoptosome assembly:
caspase 9 and APAF1. Conformational activation of caspase 9 propagates the proteolytic cascade of further
caspase activation events. In the extrinsic pathway (2) caspases are activated through the binding of extracel-
lular death ligands, like TNFα to transmembrane death receptors. It provokes recruitment of adaptor proteins,
such as FADD, which in turn recruit and aggregate several molecules of caspase 8, promoting its autoprocess-
ing and activation. Active caspase 8 proteolytically processes and activates caspase 3 and 7, provoking further
caspase activation events that culminate in substrate proteolysis and cell death. In some situations, extrinsic
death signals can interact with the intrinsic pathway through caspase 8-mediated proteolysis of the BH3-only
protein BID (BH3-interacting domain death antagonist). Truncated BID (tBID) can promote mitochondrial cy-
tochrome c release and assembly of the apoptosome. The granzyme B-dependent route to caspase activation
(3) involves delivery of this protease into the target cell trough specialized granules that are released from cy-
totoxic T lymphocytes (CTL) or natural killer (NK) cells. CTL and NK granules contain numerous granzymes
as well as pore-forming protein, porfirin, which oligomerizes in the membranes f target cells to permit entry of
the granzymes. Granzyme B, similar to caspases also cleaves its substrates after Asp residue, and can process
BID and caspase 3 and 7 to initiate apoptosis. Reprinted with changes from [149].
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apoptosis are: condensation of the nucleus and its fragmentation into
smaller pieces [82], hydrolysis of nuclear DNA into multiple fragments
[171], fragmentation of organelle‘s network: Golgi, endoplasmic reticulum
and mitochondria, and protein release from the mitochondrial intermem-
brane space [150].
During the early step of apoptosis the mitochondrial network disinte-
grates. Apoptotic stimuli activate mitochondrial fission and block fusion.
It results in mitochondrial fragmentation and condensation [49; 81]. In this
context it is closely correlated to the progression of apoptosis [92; 143].
Upon induction of apoptosis Drp1 translocates to the potential scission
sites and becomes locked on the membrane during cell death in an hFis1
- independend and Bax/Bak - dependent manner [49]. It becomes stably
sumoylated, which depends on the presence of Bax/Bak [167]. It occurs
within the same time frame as activation of the proapoptotic Bcl-2 family
member Bax and permeabilization of the mitochondrial outer membrane
which in turn leads to the release of a multiple intermembrane space pro-
teins and loss of the membrane potential [104]. Drp1 depletion blocks re-
modelling of the mitochondrial cristae [55] where cytochrome c is mostly
stored [9] and delays apoptosis [46]. In yeast, fission mediated by Drp1 ho-
molog, Dnm1, is essential for the autophagic degradation of mitochondria
[113]. Proapoptotic Bax protein co - localizes also with Mfn2 at distinct foci
on mitochondria [109] and is required for the regulation of Mfn2 activity
and lateral assembly into foci along the mitochondrial tubules [78]. This
co - localization may account for a block in fusion observed during apop-
tosis [80]. Recently, OPA1 has been shown to protect cells from apoptosis
by controlling the remodelling of mitochondrial cristae, which is indepen-
dent of its pro - fusion function [33; 51]. Out of eight OPA1 mRNA splice
forms four have fusion activity. They produce a long isoform of OPA1 in
addition to one or more further processed short forms [73]. It was demon-
strated that those various forms are produced by processing at two dis-
tinct sites: S1 encoded in all mRNA splice variants, and S2 encoded only
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in some of them [73]. There is evidence for the involvement of rhomboid
protease perselin - associated rhomboid like (PARL), mAAA and iAAA
Zn2+-dependent metalloproteases belonging to the conserved AAA fam-
ily of proteins, in the processing at those sites [61; 73; 138].
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1.3 AAA+ superfamily and AAA proteins
ATPases play crucial roles in transforming chemical energy into bi-
ological processes [114]. AAA+ superfamily of proteins (ATPases asso-
ciated with diverse cellular activities) is based on careful and multiple
alignments and crystallographic studies [110]. It contains proteins having
extremely various functions in cells, and sharing common features [114].
They are involved in processes ranging from thermotolerance in bacteria,
fungi and plants, through membrane fusion and microtubular movement
in eukaryotes, to protein degradation and DNA replication [66].
AAA+ protein family is defined by the conserved AAA+ domain. It
consists of N- and C - terminal subdomain, whose characteristics distin-
guish AAA+ domain from other nucleotide-binding proteins [66]. Its ar-
chitecture is more conserved than the underlying sequences. It is com-
posed of Walker A (also called a P-loop, GxxxxGKT where x = any amino
acid residue) and Walker B (hhhhDExx where h = hydrophobic amino
acid residue) motifs mediating ATP - binding and hydrolysis. They are fol-
lowed by sensor 1, arginine fingers and sensor 2. Conserved polar residues
of sensor 1 are physically located between Walker A and Walker B motifs
and interact with important Walker B elements and γ - phosphate of ATP.
Arginine fingers are one or two conserved arginine residues which consti-
tute part of the nucleotide - binding site of an adjacent subunit. Sensor 2
has a role in ATP hydrolysis and substrate unfolding. Its residues partici-
pate in a nucleotide binding.
A conserved region that is positioned C - terminally from the Walker B
motif named a Second Region of Homology (SRH) is a characteristic for a
subgroup of AAA+ superfamily, called AAA proteins. Its sequence is not
strictly conserved, but the proteins share comparable structural features of
SRH [74].
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1.3.1 AAA+ proteases
AAA+ enzymes assemble mostly into hexameric complexes which is
their biologically active form [66]. There has been a common mecha-
nism proposed for ATP - dependent proteolysis by proteases belonging
to the AAA+ superfamily. First, they oligomerize into barrel - shaped
micro compartments allowing sequestered proteolysis [133], and second,
ATP-dependent proteases need the energy from ATP hydrolysis to reg-
ulate the accessibility of the proteolytic sites and to unfold substrates to
drag them into the proteolytic chamber of the protease [8; 71]. The unfold-
ing process is the rate - limiting step in proteolysis [84]. The initial sub-
strate binding step does not require ATP hydrolysis, but for many AAA+
proteins ATP binding is required to generate the active, oligomeric form
of the enzyme [114].
The mechanism of ATP hydrolysis involves the nucleophilic attack of
an activated water molecule at the γ - phosphate of the ATP and the for-
mation of a penta - coordinate transition - state [114]. Negative charge
accumulating at the γ - phosphate is stabilized by the Mg2+ and by sur-
rounding of positively charged groups and/or hydrogen bond donors.
Hence, the active sites of ATPases should contain a catalytic base able to
activate nucleophilic water, and electrophilic groups able to stabilize the
negatively charged transition state, plus groups coordinating the magne-
sium ion which is an essential co - factor. The active sites contain “sensors”
which function is to “sense” the γ - phosphate and mediate the confor-
mational changes that relay this information to remote sites. ATP binding
pocket is located in between pairs of the hexamer subunits. Conserved
residues that are functionally important for ATP binding and hydrolysis
are: (1) in the Walker A motif: lysine (Lys, K) which forms ionic interactions
with β- and γ - phosphate oxygens, and threonine (Thr, T) which provides
a metal ligand; (2) in the Walker B motif: aspartate (Asp, D) which is in-
volved in the Mg2+ coordination sphere and glutamate (Glu, E) which is
a catalytic residue important for ATP hydrolysis; (3) asparagine (Asn, N),
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serine (Ser, S), threonine (Thr, T) or histidine (His, H) located at the N -
terminal end of SRH in AAA proteases forming a polar contact with γ -
phosphate of ATP and functioning as a sensor (sensor 1 [77]); (4) arginine
(Arg, R) residue at the beginning of the third α-helix in the C-domain of
the AAA+ module which in AAA proteins corresponds to the C - termi-
nal part of SRH. It mediates relative movement of the C - domain to the
N - domain during the ATP hydrolysis cycle. There are two conserved
Arg residues in AAA proteins and one in the other AAA+ family proteins.
They function as an arginine finger that transduces the chemical event of
ATP hydrolysis into the conformational changes of the neighboring sub-
unit of a hexamer. Such a coordinated cooperation of subunits greatly en-
hances ATPase activity of a complex comparing to the singular ATPase
activity of each subunit [98].
As a consequence of oligomerization, AAA proteases form a central
cavity/pore lined with residues from each subunit [66]. Most of the pore
surface is provided by the loop with three conserved residues (aromatic
- hydrophobic - glycine [163]) which have a role in a function of several
AAA proteins.
In the mitochondrial compartment both soluble and membrane ATP -
dependent proteases have been found (Fig. 1.2).
1.4 Mitochondrial proteolytic quality control
A highly conserved proteolytic system conducts the surveillance of
protein quality control within mitochondria, which has to cope with the
diverse challenges imposed on mitochondrial integrity [147]. Molecular
chaperones and energy - dependent proteases monitor the folding and as-
sembly of mitochondrial proteins and selectively remove excess and dam-
aged proteins from the organelle [87]. Key components are ATP - depen-
dent proteases, which are derived from bacterial proteases and highly con-
served in eukaryotes [87]. ATP - dependent proteases sense the folding
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state of substrates by exerting chaperone - like properties and trigger the
proteolysis of non - native proteins [147]. A central role in this process
is exerted by conserved ATPase modules, which are characteristic of the
AAA+ family of ATPases and present in all ATP - dependent proteases
[147].
1.5 Mitochondrial ATP - dependent proteases
1.5.1 ATP - dependent proteases in the mitochondrial ma-
trix
Two mitochondrial matrix proteases have been identified in various
organisms: Lon and ClpXP. Lon proteases have been identified in the
mitochondrial matrix of yeast and mammals [145; 159; 166; 165; 168]. They
harbor a catalytic serine - lysine dyad and as such are classified as serine
proteases [21; 126]. Lon forms presumably homooligomeric, ring - shaped
complexes with hexameric or heptameric structure [140]. In most cases
impaired folding appears to trigger protein degradation by Lon protease
[159]. The yeast Lon ortholog, PIM1 has been shown to degrade various
misfolded and non - assembled polypeptides, like thermally denatured
and aggregated or oxidatively damaged proteins, such as aconitase [20;
100].
Molecular chaperones of the Hsp70 and Hsp100 family co - oper-
ate with Lon protease during proteolysis by stabilizing misfolded pro-
teins against aggregation or by dissolving already aggregated proteins
[14; 124; 162]. Yeast ∆pim1 cells show inhibited growth on glycerol. Elec-
tron dense inclusions in the mitochondrial matrix could be observed pre-
sumably as a result of accumulation of non - degraded mitochondrial ma-
trix proteins [145]. Similarly, down regulation of the human Lon protease
leads to accumulation of protein inclusions, impaired mitochondrial func-
tion and apoptotic cell death [19]. It was demonstrated that Pim1p was
12
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required for the maintenance of mtDNA in yeast and present in the mito-
chondrial nucleoids, and that it was able to bind GT - rich DNA sequences
[31; 53; 52; 97]. Cellular effects of Lon deletion as well as known physi-
ologic functions of this protease suggest its regulatory function, but the
substrates and probable mechanisms it could be involved in are still un-
known.
Figure 1.2: ATP-dependent proteases in the mitochondrial matrix and in
the inner mitochondrial membrane. The Lon - protease and ClpXP (ClpP not present in
yeast) are responsible for proteolytic breakdown of misfolded polypeptides in the mitochondrial matrix. In-
tegral membrane and peripherally associated proteins are degraded by proteases of the inner mitochondrial
membrane, the iAAA protease, active on the intermembrane side of the inner membrane; the mAAA protease,
active in the mitochondrial matrix and the ATP - independent metallopeptidase Oma1, which is thought to pos-
sess catalytic domains at the side of the inner membrane. Prohibitins built up a supercomplex with the mAAA
protease. OM - outer membrane; IMS - intermembrane space; IM - inner membrane; M - mitochondrial matrix.
Reprinted with modifications from ([112]
The other mitochondrial matrix protease ClpX (caseino-lytic protease)
was found in all organisms whereas ClpP only in mammals and plants,
but not yeast [37; 76; 160]. In contrast to Lon- and AAA proteases, their
ATPase domain and the proteolytic domain are expressed as separate gene
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products. The ATPase domains (ClpX, ClpA) assemble into hexameric,
ring complexes with ATPase and chaperone activity, while the proteolytic
domains (ClpP) form heptameric, double ring complexes. The ATPase
domains determine the substrate specificity of the Clp protease and also
exert regulatory functions during proteolysis [17; 117; 133; 169].
1.5.2 ATP dependent proteases in the mitochondrial mem-
branes
Two membrane bound AAA proteolytic complexes have been iden-
tified in mitochondria. They are integrated into the inner mitochondrial
membrane and build up of orthologs of FtsH - membrane bound AAA
protease essential for cell viability in Escherichia coli [2; 154; 155].
In yeast there are three FtsH orthologues: Yta10p and Yta12p forming
a heterohexameric mAAA protease complex active at the matrix side, and
Yme1p which is the only enzymatic component of iAAA protease active
in the intermembrane space. They share several common features: N - ter-
minal targeting signal followed by the AAA consensus and HEXXH motif
characteristic for metallopeptidases of the thermolysin family M41 [123].
Mutation of the glutamate residue within the proteolytic centre inhibits
protein degradation by AAA proteases [7]. Opposite orientation of cat-
alytic domains of iAAA and mAAA proteases is a consequence of having
one or two transmembrane domains respectively (Fig. 1.3). AAA protease
- mediated degradation of membrane proteins involves dislocation or ex-
traction of the substrate from the membrane [95]. This process requires
around 20 residues to protrude from the membrane surface [32] probably
to reach deep into the ATPase domain and establish productive binding.
Mutational analysis of a conserved loop motif YVG (aromatic - hydropho-
bic - glycine) present in the central pore of hexameric AAA+ ring com-
plexes [164], indicates substrate translocation into the proteolytic chamber
through the central pore of mitochondrial AAA proteases [59]. Recently,
14
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Tatsuta et. al. has shown the ability of the mAAA protease to mediate vec-
torial membrane dislocation of proteins in an ATP - dependent reaction
[146]. This membrane extraction of substrate proteins is likely to be facili-
tated by the membrane - embedded parts of AAA protease subunits which
might form a pore - like structure or provide at least a more hydrophilic
environment [88].
Figure 1.4: Folding of the yeast iAAA protease and substrate engagement
Side view of crystal structure of Thermotoga maritima FtsH [15] showing three subunits was used as a model
for mapping the substrate binding regions of the yeast iAAA. Two identified regions CH and NH (red and
green helices respectively) of the yeast Yme1p responsible for substrate engagement are located on the surface
of proteolytic cylinder (CH helices marked on PD) and AAA domain (NH helices marked on AAA). AAA, AAA
domain; PD, proteolytic domain; IM, inner membrane. Reprinted with modifications from [87].
Two FtsH structures from two eubacterial organisms have been solved
recently [15; 90; 144] which facilitated studies on the yeast iAAA protease
subunit Yme1p. It allowed the localization of two helical binding regions.
The C - terminal helices of the proteolytic domain (CH - region) and the
16
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N-terminal helix (NH-region) in the AAA domain form a lattice-like struc-
ture at the surface of the proteolytic cylinder and mediate the initial en-
counter of substrate proteins with the protease (Fig. 1.4, [58; 87; 94]). The
NH - region is located in a close proximity to the membrane surfaces and
highly negatively charged. Thus, substrate proteins initially interact with
the iAAA protease at the outer surface of the proteolytic cylinder, before
they enter the proteolytic chamber. Interestingly, the binding properties
of the surface - exposed interaction sites vary suggesting that alternative
pathways for substrate entry into the proteolytic chamber of iAAA pro-
teases exist. The CH - region is only required for the binding and degra-
dation of a subset of proteins. The distance of an unfolded domain from
the membrane surface, might be one parameter determining the involve-
ment of the CH - region for substrate binding. In case of a non - assembled
subunit 2 of the cytochrome c oxidase, Cox2p, destabilization of the sol-
vent - exposed Cox2 domain at high temperatures renders CH - dependent
proteolysis by the iAAA protease [58]. In contrast to the CH - region, the
NH - region appears to be generally involved in proteolysis. It is therefore
likely that CH - dependent substrates bind in a sequential manner at CH-
and NH - regions before they enter the proteolytic chamber through the
central pore formed by the AAA domains [87].
Growing evidence suggests that substrate binding and proteolysis by
AAA proteases is modulated by additional factors within mitochondria
[87]. It can appear in a substrate - specific manner. Like Cox20p which
affects proteolysis of the Cox2p by the iAAA protease modulating recog-
nition of a substrate [58]. Proteolysis of the non - assembled Cox2p was
demonstrated to be strictly dependent on the CH - region in Cox20 - defi-
cient mitochondria, but not in the presence of Cox20p [58] indicating over-
lapping functions of Cox20 and CH - region of Yme1p. Another co - factor
for iAAA protease is also not essential for proteolysis [42]. Together with
Yme1p, Mgr1 is part of the iAAA proteolytic complex in yeast [42]. It was
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suggested to act as an adaptor - like protein which targets specific sub-
strates in the IMS for degradation by iAAA protease [87].
No substrate-specific co-factors of mAAA protease have been identi-
fied so far. However, the yeast mAAA protease is part of a large super-
complex with prohibitins, which modulate proteolysis [141]. Prohibitin
1 (Phb1p) and prohibitin 2 (Phb2p) are ubiquitous and highly conserved
subunits of those supercomplexes. They assemble in a multimeric complex
which is exposed in the intermembrane space and anchored N-terminally
to the inner membrane [11; 111; 141]. Deletion of prohibitins results in ac-
celerated protein degradation by the mAAA protease [141]. However it is
not yet understood how they affect the proteolysis by the mAAA protease.
Both the m- and the iAAA protease recognize and degrade non-native
and non-assembled polypeptides to peptides [7; 96]. These proteases ex-
hibit degenerate substrate specificity and, similar to molecular chaper-
one proteins, recognize the folding state of solvent-exposed domains of
membrane proteins [94]. mAAA and iAAA proteases are the main compo-
nents of mitochondrial quality control. They degrade proteins to peptides,
which are subsequently either exported from the organelle or degraded
further to amino acids by various oligopeptidases [147].
Yeast cells lacking both m- and iAAA proteases are not viable demon-
strating the crucial function of this proteolytic system for cellular home-
ostasis [93; 95]. Their depletion or inactivation causes severe pleiotropic
phenotypes in various organisms, which are best characterized in the yeast
Saccharomyces cerevisiae. Here, all observed defects can be attributed to a
loss of the proteolytic activity as identical phenotypes were observed after
deletion of an AAA protease subunit or after inactivation of the proteolytic
sites of all subunits of AAA protease complexes [6; 96; 170]. Both pro-
teases exert overlapping functions within mitochondria, having overlap-
ping substrates; however different phenotypes resulting from mutations
indicate substantial differences.
YTA10 and YTA12 yeast mutants exhibit respiratory incompetence
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[62; 148] and lack assembled respiratory chain and ATP-synthase com-
plexes in the inner membrane [54; 118; 158]. Yeast mAAA protease was
found to degrade non assembled mitochondrialy encoded respiratory
chain subunits. Also peripheral membrane protein such as Atp7 was iden-
tified as a mAAA substrate [88]. Recently, a subset of specific substrates
was identified proving a regulatory, housekeeping function of mAAA
protease. That includes proteolytic cleavage of a conserved, nuclearly en-
coded subunit of mitochondrial ribosomes MrpL32 [112] and cytochrome c
peroxidase (Ccp1), a heme-binding ROS scavenger in the intermembrane
space [45; 146]. Maturation of Ccp1 within mitochondria represents the
first non-proteolytic function of the mAAA protease in the mitochondrial
biogenesis, and rather severe mutant phenotypes of YTA10/YTA12 could
be explained not only by loss of respiration but also by the overall mito-
chondrial malfunction.
SPG7 - a mammalian homologue of the yeast mAAA protease sub-
units was identified in the genetic screen of patients affected with an au-
tosomal, recessive, neurodegenerative disorder called Hereditary Spastic
Paraplegia (HSP) [24]. Further identification of mammalian AAA pro-
teases homologues followed. Complementation studies identified a com-
plex of mammalian paraplegin and AFG3L2 as the functional orthologue
of the yeast mAAA protease [12; 112] and a knock-out mouse model was
generated [47] where the human phenotype of the disease was repro-
duced. It has been proposed that mAAA mutations mapped in the HSP
patients led to the defects in an axonal transport of mitochondria, result-
ing in the energy insufficiency and a neuronal decay [47]. AFG3L2 was
shown to homooligomerize, which was proposed to be responsible for in-
creased severity of the Afg3l2 mutants [87; 101].
The mammalian mAAA protease was linked to the transmembrane
potential-dependent proteolysis of OPA1 [43; 73] together with a mam-
malian rhomboid protease PARL [33] and prohibitin 2 (PHB2) - a part
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of a prohibitin-mAAA supercomplex, is involved in the OPA1-dependent
cristae remodeling in mitochondria [106].
Yeast lacking YME1 lose mtDNA at an accelerated rate forming pe-
tite negative colonies, i.e. unable to grow on glucose in the absence of
mtDNA. ∆yme1 cells fail to grow on a non fermentable carbon source at
37°C , as well as on glucose at 14°C [23; 152]. The yme1 mutant cells show
deficient oxygen consumption and mitochondrial morphological abnor-
malities: from abbreviated branched structures to swollen forms, together
with alterations in protein/lipid composition. Mitochondrial abnormali-
ties could be partially reversed in S.cerevisiae by mutations of YNT1 gene
encoding a 26S protease subunit suggesting similar functions [23]. The
Yme1p is immunologically detectable as an 80 kDa protein present in the
mitochondria [153]. It has a role in the degradation of unassembled in-
ner membrane protein complexes, like cytochrome c oxidase subunit 2
[121] and Phb1p and Phb2p [75] as well as external NADH dehydroge-
nase (Nde1) [13]. Rainey et al. reported crucial non-proteolytic function of
Yme1p in the import of an exogenously expressed human PNPase [122] -
mitochondrial intermembrane space protein required for the maintenance
of mitochondrial homeostasis [29]. Selective removal of malfunctional mi-
tochondria in the autophagic process, named mitophagy [83] suppresses
apoptosis and has a cytoprotective function [99]. Interestingly, recent re-
ports suggest a new function of Yme1p, namely the proteolytic turnover of
a mitochondrial inner membrane protein phosphatidylserine decarboxy-
lase 1 (Psd1p) responsible for the synthesis of phosphatidylethanolamine
- an essential mitochondrial component, having function in the autophagy
[108].
Human ortholog of Yme1p has been identified in the complementa-
tion studies [134]. It has been expressed in the ∆yme1 yeast cells rescu-
ing the temperature-sensitive phenotype, and demonstrating functional
complementation and conservation of the iAAA complex [134]. Human
YME1L1 (Yme1-like 1, further related to as YME1L) and paraplegin have
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42% and 33% homology with the yeast Yme1p respectively. Expression
and immunofluorescence studies revealed that YME1L and paraplegin
share similar expression pattern and the same subcellular localization [36].
Two transcript variants encoding different isoforms have been found for
the human gene. Transcript variant 3 lacks an internal coding exon 3
compared to transcript variant 1. However, it maintains the same read-
ing frame, and encodes an isoform 3 (716 aa; 80kDa) that is missing a
57 aa segment compared to isoform 1 (773 aa; 86.5kDa). The exon 3 en-
codes an N-terminal part of the protein, which is presumably processed
off upon import of YME1L into the mitochondria. There is only one tran-
script variant annotated for the murine Yme1l1 encoding only one form of
YME1L: 715 aa, 80kDa. Because of the high conservation and homology
(see alignment and homology tree in the Appendix 1 on page 81) possi-
ble involvement in spastic-like disorders has been suggested for the mam-
malian iAAA protease [36; 134]. However, Coenen et al. [35] failed to iden-
tify YME1L mutations in patients with combined defects in the oxidative
phosphorylation system. Only recently, it has been suggested that YME1L
may have a function in a novel apoptotic pathway independent of cas-
pases [57]. Thus, the mammalian iAAA protease is believed to have an
additional role in the regulation of mitochondrial dynamics and morphol-
ogy, independent of its proteolytic quality controlling in the mitochondria.
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Aim of the thesis
Identification of the YME1L as an ortholog of the yeast iAAA pro-
tease subunit opened a question about its action and its importance for
the mammalian cell. Little is known about the mammalian iAAA protease
complex as no functional studies were done on that protein. The question
was, whether evolutionary conservation of the protein results in a func-
tional conservation within the mitochondria. To address it and to examine
the relevance of the mammalian iAAA protease for mitochondrial mor-
phology, proteolysis and function two approaches were carried out:
• YME1L down regulation studies in the mammalian cells and
• overexpression studies of the wild-type and various mutant variants
of the YME1L protein in the mammalian inducible system.
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Results
3.1 Down regulation of YME1L using small in-
terfering RNAs (siRNAs)
3.1.1 Specific antibody against YME1L
The proper recognition of the protein by the antibodies used through-
out the study was verified prior to the verification of the efficiency and
specificity of YME1L down regulation and its overexpression in mam-
malian cells. As a reference for the running behavior on SDS-PAGE of the
mature YME1L data were used from the in vitro processing of the human
YME1L by the matrix processing protease (MPP; Figure 3.1A; courtesy of
Dr Mirko Koppen). The cloned construct was encoding human isoform 3,
i.e. having 716 amino acids in length (80kDa) which was also used by Shah
et al. in complementation studies [134]. The hYME1L was transcribed and
radiolabeled in a cell-free system and incubated at 30°C for 20 min with
the MPP purified from E.coli. In the next experiments three different anti-
bodies were checked for the recognition specificity:
• polyclonal antiserum raised against hYME1L protein (Figure 3.1B
and C, kind gift of Dr Carla Koehler);
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• affinity purified polyclonal antiserum SPY531 raised against two
peptides common for the murine and human protein sequence:
(152-166aa) TLKSRTRRLQSTSER and (517-531aa) DKILMGPERRS-
VEID (Fig. 3.1D);
• commercial polyclonal antibody (ptglab; Fig. 3.1E).
Figure 3.1: Recognition of the mature YME1L by different antibodies used
in the present work
A. Human YME1L processing in vitro by the matrix MPP protease. Mature form of the hYME1L runs at
the size of ∼60kDa. Efficiency of the processing was controlled by Su9-DHFR, a construct cleaved by MPP
(courtesy of Dr Mirko Koppen). Four different antibodies used in the present work were checked for specific
recognition of YME1L by comparison of the size of bands recognized in Western blotting. As a reference for
the proper band size, in vitro processing of hYME1L was used (A.). With numbers 1-3 are marked cell lysates
from HeLa cells transfected with siRNA1-3; and 4-6 show lysates form MEF cells transfected with siRNA4-6.
Extracts from the scrambled negative siRNA control and non-transfected cells were used as protein down
regulation reference. WB refers to cell extract from HEK293 Flp-In clone expressing mYME1LE381Q induced
with 1µg/ml tetracycline for 24h. β-actin was used as a loading control (anti β-actin 1:5000, Sigma, clone AC15);
B.-C. polyclonal antiserum raised against hYME1L protein (kind gift of C.Koehler) specifically recognized both
human (B.) and murine (C.) YME1L; D. polyclonal antiserum SPY531 raised in the present study against two
peptides from the murine YME1L recognized specifically both human (scrambled) and murine (WB) YME1L E.
commercial polyclonal antibody (ptglab, 1:500 dilution) recognized human YME1L protein.
In all of the cases the antibodies recognized specifically a band running
on SDS-PAGE at the size of ∼60kDa, which disappeared upon siRNA
transfection i.e. down regulation of YME1L protein in all of the used cell
lines: HeLa (Fig. 3.1B and E) MEF (Fig. 3.1C) and HEK293 (Fig. 3.1D). As
reference cell extracts were used from cells transfected with a scrambled
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negative siRNA control (Invitrogen) as well as from non-transfected cells.
The size of the protein running at that position is in agreement with the
size of the mature hYME1L processed in vitro (Fig. 3.1A.). The exclusive
disappearance of the 60 kDa band was observed only upon siRNA1-6
transfection which demonstrates specificity of the antibody recognition.
3.1.2 Depletion of YME1L in mammalian cells
Three different siRNAs were used to down regulate the YME1L expres-
sion on the mRNA level. For human YME1L (hYME1L) that were siRNA1,
siRNA2 and siRNA3, whereas siRNA4, siRNA5 and siRNA6 were de-
signed against murine YME1L (mYME1L). All sequences hybridize within
the coding sequence. Scrambled negative control (Invitrogen) i.e. siRNA
duplexes with no match to the mRNA of YME1L, was used as a control.
It allowed verification of a knock down specificity on YME1L. Western
blot analysis revealed the most efficient down regulation in the case of
siRNA1 and 2 for hYME1L (Fig. 3.1B lane 1 and 2) and siRNA4 and 6 for
mYME1L (Fig. 3.1C and not shown data). The protein was reduced to a
level which was not detectable by immunoblotting with any of the used α
YME1L antibodies. siRNA 1, 2 and siRNA 4 and 6 were chosen for further
experiments.
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3.1.3 Mammalian YME1L role in proteolysis
Proteolysis of PHB1 upon depletion of its assembly partner PHB2
Depletion of PHB2 in mammalian cells is accompanied by the loss of
its assembly partner PHB1; however, transcription of Phb1 was shown not
to change [106]. This suggests proteolysis of PHB1 while the PHB2/PHB1
complex is destabilized upon absence of PHB2; an effect that was observed
previously in yeast [75]. Therefore, the PHB1 steady-state level was as-
Figure 3.2: YME1L degrades PHB1 upon destabilization of the prohibitin
complex
Cell extracts from MEFs transfected with siRNA designed against mYME1L (4 and 6) and against mPHB2 (Y)
or both of them (4Y) were analyzed after 48-60h post transfection by immunoblotting with α YME1L (ptglab), α
PHB1 (NeoMarkers) and α PHB2 (BioLegend). Cells transfected with scrambled siRNA were used as reference
control. Immunoblotting with α complexII antibody (Molecular Probes) was used as a loading control.
sessed in PHB2 deficient MEF cells by single (siRNA4 and 6 against Yme1l,
siRNAY against Phb2) or double siRNA transfection (siRNA4 and Y; Fig.
3.2) to verify the potential role of YME1L in PHB1 degradation. In the case
of single transfections Western blotting showed an efficient and specific
down regulation of YME1L (Fig. 3.2, lane 2 and 4) while neither the level
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of PHB1 and PHB2, nor complex II used as a loading control, changed.
Similarly, efficient depletion of PHB2 (Fig. 3.2, lane 3) did not lead to de-
pletion of YME1L or complex II. It led however to destabilization of PHB1.
Simultaneous knock down of PHB2 and YME1L (Fig. 3.2, lane 1) stabilized
PHB1 to the wild-type level (scrambled control). This indicates a role of the
YME1L protein in the degradation of the unassembled prohibitin complex
subunit - PHB1. This finding clearly shows that structural conservation of
Yme1p throughout the evolution (compare with Fig. 1.3) results also in the
functional conservation of the protein, as Phb1p was shown before to be a
specific substrate for the yeast iAAA protease [75].
YME1L role in the new apoptotic pathway
The molecular bases of phenotypes associated with a deletion of YME1
in yeast as well as the phenotypes observed upon down regulation of
YME1L in mammalian cells are poorly understood. It appears likely that
they are connected with the diverse roles of the so far undiscovered
substrates of the iAAA protease. Given those pleiotropic functions, we
wanted to examine further effects of YME1L down regulation in the mam-
malian cells. Recently, Goemans et al. have reported a new apoptotic path-
way activated by mitochondrial outer membrane permeabilization and in-
hibition of caspases [57]. It involves a specific TIM23 degradation which
impairs mitochondrial import and inhibits cell proliferation. Tim23p is
a central component of the TIM23 translocase complex in the inner mi-
tochondrial membrane, crucial for the pore formation [107]. It was fur-
ther shown that TIM23 degradation depends on factors residing in the
mitochondria. The authors proposed this novel apoptotic pathway as an
“emergency exit” for the apoptosis to occur upon inhibition of caspases.
To investigate the specific function of YME1L in TIM23 degradation, apop-
tosis was induced with 200µM or 50µM etoposide (Eto, Fig. 3.3A, B) in
the cells transfected with siRNA against YME1L and scrambled negative
control (scr). Cells were treated with 10µM caspase inhibitor Q-VD-OPH
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Figure 3.3: Stabilization of TIM23 upon YME1L down regulation
HeLa cells transfected with siRNA and scrambled negative control (scr) were treated with 200 µM (A.) and
50 µM (B.) of an apoptotic stimulus (Eto) in the presence or absence of caspases inhibitor (OPH) for 24h and
48h respectively. Destabilization of TIM23 (α TIM23, BD Biosciences) observed upon simultaneous apoptosis
stimulation and inhibition of caspases can be rescued by siRNA knock down of YME1L (α YME1L, ptglab).
Immunoblotting with α complexII antibody (Molecular Probes) served as a loading control.
(OPH). Inhibition of caspases simultaneous with the apoptosis induction
resulted in TIM23 destabilization as shown on Fig. 3.3A lane 2, and 3.2B
lane 3. Knock down of YME1L stabilized the protein, revealing YME1L
role in the apoptosis- and caspases inhibition-induced specific degrada-
tion of TIM23. The effect was stronger with 50µM etoposide treatment for
48h, than 200µM etoposide for 24h, suggesting that this pathway is rather
late reacting.
3.1.4 YME1L role in mitochondrial biogenesis
Mitochondrial morphology of the mammalian cells
Next, the effects of YME1L depletion on the mitochondrial morphol-
ogy were addresses in human HeLa cells and murine MEFs. To this end
both types of cells were transfected with siRNA against YME1L to knock
down the protein. Subsequently, cells were transfected with a plasmid en-
coding mitochondrialy targeted red fluorescent protein (pDsRed2-Mito)
for the visualization of mitochondria by fluorescent microscopy. We used
cells transfected with the scrambled negative control as controls (Fig. 3.4B)
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Figure 3.4: Aberrant mitochondrial morphology in the absence of YME1L
A. - E. HeLa cells were transfected with: siRNA1 (C. a, b, c) siRNA2 (D. a, b, c) siRNA3 (E. a, b, c) designed
against human YME1L mRNA, and scrambled negative control (B.) or no siRNA (A.) followed by pDsRed-Mito
(1 µg) transfection and analyzed by fluorescence microscopy after 48-60 h post-transfection. Different morpho-
logical types of mitochondria were quantified (F.) and compared to controls: HeLa transfected with scrambled
negative control siRNA (scrambled) and pDsRed-Mito (1 µg), HeLa cotransfected with pcDNA3.1Hygro empty
plasmid and pDsRed-Mito (4:1, 1 µg of total plasmid DNA) (WT+VEC), HeLa transfected with siRNA1 and
co-transfected with pcDNA3.1Hygro:pDsRed-Mito (4:1, 1 µg of total plasmid DNA) (siRNA1+VEC). 100 cells
were calculated for each sample. G. - L. MEF cells transfected as A. - E. with no siRNA (WT control; G.); scram-
bled negative control (H.) and siRNAs designed against murine YME1L mRNA: siRNA4 (J.) siRNA5 (K.) and
siRNA6 (L.). Yellow arrows point to the non affected cells with mitochondrial morphology as in the control
cells.
as well as cells not transfected with siRNA (WT, Fig. 3.4A). In all of tar-
get siRNA-transfected cells we could see aberrant mitochondria. From
swollen but still interconnected branches (Fig. 3.4Cb, Ea-c) to the com-
plete lack of the network (Fig. 3.4Ca, Dc, J, K, L). HeLa cells were quanti-
fied: 100% cells transfected with siRNA1 had fragmented/aggregated mi-
tochondria; 90% transfected with siRNA2 and 97% with siRNA3. None
of the transfected HeLa cells had wild-type mitochondrial tubular net-
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work. Only 6% of the cells transfected with scrambled control had frag-
mented mitochondria. WT and siRNA1 transfected cells were addition-
ally co-transfected with an empty pcDNA3.1Hygro vector (VEC) to ex-
clude deleterious effect of plasmid transfection. They had 2% and 97%
of fragmented mitochondria respectively. Even in the populations, where
Western blotting analysis still revealed residual levels of the YME1L pro-
tein (Fig.3.1B lane siRNA3) almost all of the cells showed abnormal mi-
tochondrial morphology. That could indicate the primary effect of down
regulation of YME1L on mitochondrial network not tightly related to its
high enzymatic/proteolytic activity. Similar mitochondrial phenotypes in
the MEFs transfected with siRNA4-6 were observed (Fig. 3.4J-L). The frag-
mentation/aggregation was even more striking than in HeLa cells (Fig.
3.4J, K). However, the transfection efficiency was lower as mixed popu-
lations of cells having aberrant and wild-type morphology could be seen
(Fig. 3.4L).
OPA1 processing in the YME1L knocked down cells
The dynamin-related GTPase OPA1 is essential for the maintenance of
cristae in the mitochondrial inner membrane and for mitochondrial fusion
[116; 138]. There are eight OPA1 splice variants which are proteolytically
processed to two long isoforms (L1 and L2) which can be in turn processed
to three short isoforms (S3-S5). S4 is a form that appears to be generated
by YME1L [61; 73; 138]. In further experiments a relation of mitochondrial
abnormalities in MEFs (Fig. 3.5A) to accumulation of the different OPA1
forms (Fig. 3.5B) was examined. Immunoblotting of the MEF cells trans-
fected with siRNA4 revealed alterations in OPA1 cleavage (Fig. 3.5B, lane
2). Longer isoforms are absent (L1) or present in the smaller amount (L2)
and the shorter isoforms accumulate. This effect is in line with the aber-
rant morphology visible by fluorescent microscopy (Fig. 3.5A). Notewor-
thy is the difference in mitochondrial morphology of cells transfected with
siRNA against PHB2 (siRNA Y), and YME1L (siRNA 4). Mitochondria in
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Figure 3.5: Processing of OPA1 depends on the presence of YME1L
Lysates from the MEF cells transfected with siRNA against murine YME1L (4), murine PHB2 (Y) or both of
them (4Y) were checked for OPA1 expression pattern by immunoblotting with the anti-OPA1 antibody (BD
Biosciences). Ponceau S staining (PS) serves as a loading control. Fluorecence microscopy (A.) of indicated cell
samples shows mitochondrial morphology effect in relation to OPA1 processing (B.). Scrambled transfection
control (scrambled, SCR) and wild-type cells (MEF WT) were used as reference controls.
cells lacking PHB2 are small and dispersed, no elongated forms are visible.
No interconnections are present. Mitochondria from cells lacking YME1L
are bigger, swollen with visible interconnections. Therefore they resemble
more aggregated than fragmented tubular network. Recently, PHB2 was
shown to influence the OPA1 processing and cristae remodeling, with the
mitochondrial fragmentation as PHB2-depletion effect [106]. Apparently,
PHB2 down regulation has an epistatic effect over YME1L down regula-
tion, since double knock down of the proteins (siRNA 4 and Y) results in
the morphology resembling single PHB2 depletion (Fig. 3.5A).
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Mitochondrial transmembrane potential maintenance in the YME1L
knocked down cells
Mitochondrial dysfunction and dissipation of the membrane potential
across the inner membrane can induce OPA1 processing and lead to mito-
chondrial fragmentation [44; 73; 106]. The YME1L knock down could also
Figure 3.6: YME1L affects mitochondrial morphology but not respiration
A. Aberration in the mitochondrial morphology upon down regulation of YME1L by 3 different siRNAs: 1
(a.) 2 (b.) and 3 (c.) in HeLa cells transfected with pDsRed-Mito and analyzed after 48-60 h by fluorescence
microscopy. Scale bar 2 µm. B. Maintenance of mitochondrial transmembrane potential in YME1L-deficient
HeLa cells. Indicated cell samples were stained with the fluorescent dye JC1 and analyzed by flow cytometry
at 590 nm. Dissipation of the membrane potential with CCCP both in wild-type HeLa cells and transfected
with siRNAs 1 and 2 or scrambled control, together with DMSO treated cells were used as controls. White
bars represent the percentage of cells giving red and green signal whereas black bars show percentage of cells
giving only green signal, e.g. with the dissipated membrane potential. C. Immunoblot analysis of siRNA 1-3
transfected HeLa cells. Steady state levels of respiratory chain proteins: complex II (Molecular Probes), complex
V (Molecular Probes) and complex IV subunit 2 (COX2; Molecular Probes) were analyzed by SDS-PAGE of
total cell lysates and immunoblotting with the specific antibodies. Scrambled siRNA transfected and non
transfected cells serve as reference controls. Immunoblotting with an anti-YME1L antibody (Dr. C. Koehler)
shows YME1L-specific siRNA down regulation efficiency.
impair the transmembrane potential. That would explain induced OPA1
processing and mitochondrial morphology abnormalities (Fig. 3.6A). To
examine this possibility, siRNA transfection was repeated. Subsequently
cells were stained with JC1 (Molecular Probes). This is a fluorescent dye,
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whose oligomerization in the living cell takes place in mitochondria and
depends on the presence of the mitochondrial potential. JC1 aggregates
in the mitochondria emitting a red fluorescence, or/and stays in the cy-
tosol as monomer, emitting a green signal. Thus, in normal cells with
transmembrane potential present, both red and green signals are present,
while no red signal can be detected upon dissipation of the membrane
potential. siRNA1 and siRNA2 were used, as the most efficient in down
regulating YME1L levels. Wild-type HeLa cells and the negative siRNA
control were used to exclude deleterious effect of the transfection. CCCP
(carbonyl cyanide m-chloro-phenyl-hydrazone) treatment was used as a
positive control for the transmembrane potential dissipation. CCCP is an
uncoupling agent which abolishes the obligatory linkage between the res-
piratory chain and the phosphorylation system observed with intact mi-
tochondria. Cells were subjected for fluorescence-activated cell sorting
(FACS) and quantified (Fig. 3.6B). The membrane potential was main-
tained in YME1L depleted HeLa cells. Furthermore, respiratory chain
complex II, complex V and cytochrome c oxidase subunit 2 (COX2) steady
state levels were not affected (Fig. 3.6C). Taken together, increased OPA1
processing and mitochondrial fragmentation in YME1L-depleted cells is
not caused by an impaired transmembrane potential or respiratory activ-
ity. These findings are in agreement with the previous reports showing ab-
normalities in the mitochondrial network upon YME1L down regulation
[61] proposing YME1L role in the processing of OPA1 in a constitutive
and transmembrane potential-independent manner at the S2 processing
site [63; 138].
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3.2 Overexpression of YME1L in the inducible
system: HEK293 T-REx Flp-In cells
3.2.1 Expression constructs
Mitochondria depend on the functional iAAA and mAAA inner mem-
brane proteases. The mAAA protease subunits paraplegin and AFG3L2
were reported in the pathogenesis of Hereditary Spastic Paraplegia [24;
25; 127], axonal development [101], in the maintenance of mitochondrial
morphology [43; 73] and in the proteolytic cleavage/maturation of other
mitochondrial proteins [112; 146]. Similarly, the present study reports a
role of the iAAA protease in mitochondrial morphology, apoptosis and
specific degradation. However, little is known about the mechanisms that
could carry out those functions. Recent mutational studies on the yeast
Yme1p revealed different modes of substrate binding [58] which could
participate in different effects of gene deletion or Yme1 protein mutation
on its different functions. Furthermore, studies on the mAAA protease
have shown that a mutation of the conserved glutamate residue in the
Walker B motif, required for ATP hydrolysis has a dominant negative ef-
fect on the mAAA complex (personal communication: Ines Raschke, Flo-
rian Gerdes, Dr Takashi Tatsuta and Dr Steffen Augustin). It is therefore
conceivable, that similar mutation in iAAA could lead to the similar ef-
fect. To test that possibility we constructed several expression constructs
encoding different variants of murine YME1L (Fig. 3.7A). Mutations were
introduced into:
• the lysine residue required for ATP binding in the Walker A motif
(mYME1K327A; WA),
• the glutamate residue of the Walker B motif required for ATP hydrol-
ysis (mYME1LE381Q; WB),
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• the glutamate residue responsible for enzymatic activity in the pro-
teolytic domain (mYME1LE542Q; EQ),
• highly conserved glutamate residue which has not been yet reported
as essential for any of the functions of AAA proteases (mYME1LE603Q;
Ct see also Fig. 1.3 and Appendix 1 on page 81 for the sequence align-
ment).
An additional construct with a wild-type variant of mYME1L (mYME1LWT ;
WT) was prepared for a control. The protein was C-terminally tagged with
StrepII tag followed by eight histidine residues (8HIS). They were intro-
duced to allow:
• differentiation of the endogenously and exogenously expressed pro-
teins by immunoblotting with an antibody against the tags.
• two-step protein purification using affinity chromatography
• pull down of YME1L-substrate complexes
All the constructs were cloned into a vector allowing inducible expression
(pcDNA5/FTR/TO™ ) and stable HEK293 lines were generated with a
help of Flp-In™ system (Invitrogen).
3.2.2 Generation of stable cell lines
The Flp-In™ system allows single genome integration of the cod-
ing cassette through Flp-driven recombination between two FRT sites
(Fig. 3.7B). HEK293 T-REx™ Flp-In™ cells harbor one FRT site within
a LacZ-Zeocine cassette integrated into the genome. The second FRT se-
quence is located on the pcDNA5/FRT/TO™ vector. Sequences encoding
the Gene of Interest (GOI, Fig. 3.7B) are cloned into the pcDNA5/FRT/-
TO™ vector under a tetracycline-inducible promoter (PCMV/2xTetO2).
The pOG44™ plasmid harbors a coding sequence for Flp recombinase.
Both are co-transfected into HEK293 T-REx Flp-In™ cells. Constitutively
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expressed Flp mediates trans recombination between both FRT sites. As
a result, the whole pcDNA5/FRT/TO™ plasmid with GOI gets inserted
into the HEK293 genome and the LacZ-Zeocine cassette gets disrupted
and cells lose zeocine resistance. They gain, however, hygromycine re-
sistance which allows positive selection. Clones isolated after ten days
selection with hygromycine were verified for a correct genome inser-
tion by β-galactosidase activity test. It is based on the presence of the
functional LacZ cassette in the genome of non-transfected cells and cells
where random integration occurred. In the test they are stained blue, as
β-galactosidase is active. No strain reports LacZ disruption i.e. proper in-
tegration of the coding construct into the genome (Fig. 3.7C).
3.2.3 Test of expression
In the following experiment, clones showing negative staining in the
β-galactosidase activity test were subjected for 24h to tetracycline (tet)
induction of YME1L expression. Mitochondria were isolated from non
- induced and tet-induced cells to examine the relative expression level
(Fig. 3.8A). Positive stable cell line clones were obtained for all of the con-
structed mYME1L variants. In all of the checked mitochondrial lysates an
increase of the protein expression was detected in response to the tetra-
cycline induction. As seen on Fig. 3.8A there is no band shift, despite of
C-terminal double tag, 20 kDa in size, included in the expression con-
structs. The YME1L bands in non-induced cells represent the endogenous
protein, whereas from tet-induced both: endo- and exogenously expressed
protein. Batch purification of the protein from cleared cell lysates (Qiagen,
according to the QIAexpressionist protocol) on Ni-agarose affinity column
(Qiagen) failed, as well as a detection of the protein with α StrepII an-
tibody (results not shown). We conclude therefore, that both StrepII and
8 HIS tags are lost, presumably cut off in proteolytic processing. It was
therefore impossible to differentiate endogenous and exogenous forms of
YME1L expressed in HEK293 cells.
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Figure 3.8: Overexpression of wild-type or mutant forms of mYME1L has
no effect on the growth rate
A. Correct insertion into the genome was verified by comparison of YME1L protein level before and after
induction: one part of the cells was treated with 1?g/ml of tetracycline for 24h (+Tet) and the other part was
left without induction (-Tet). Both sets of cultured clones were subjected for mitochondria isolation and YME1L
level was examined by immunoblotting with the commercially available YME1L-specific antibody (ptglab).
Indicated clones expressed the following forms: wild-type mYME1L (WT4), mYME1LK327A (WA4, WA6),
mYME1LE381Q (WB9), mYME1LE542Q (EQ7) and mYME1LE603Q (Ct2). B. Proliferation assay (Promega) with
1 µg/ml tetracycline induction (right panel) or without (left panel). HEK293 Flp-In™ T-REx™ control cells
together with clones expressing wild-type YME11L were used as reference controls. Each clone was seeded and
measured in 4 repeats.
3.2.4 Characterization of mYME1L expressing cell lines
Overexpression effect on the cellular growth
The effect of any of the introduced mutations on the cellular prolif-
eration was examined. Deficiencies in other mitochondrial proteins, like
PHB2 were shown to inhibit the proliferation of MEF cells [106] and
Walker B motif mutation in the murine AFG3L2 inhibits the growth of
HEK293 Flp-In™ T-REx™ cells (Ines Raschke personal communication).
Therefore, the proliferation assay was performed with tetracycline induc-
tion for 8 days (Promega, CellTiter96AQueous One Solution Cell Prolifera-
tion Assay). Cells were counted every 24h. Tetracycline was freshly added
every 24h due to its low stability. We did not observe any inhibitory effect
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of the mYME1L WT or mutant variants overexpression on the cell growth
(Fig. 3.8B) when compared to the HEK293 control cells.
Subcellular localization of the overexpressed mYME1L forms
In further experiments the subcellular localization of the overexpressed
protein was approached. Both StrepII and 8HIS tags could not be de-
tected. Therefore endogenous and exogenously expressed YME1L could
not be distinguished from each other. The subcellular localization of the
protein was assessed by immunofluorescence with the specific polyclonal
anti-YME1L antibody. To this end, transfection of the mitochondrially tar-
geted red fluorescent protein was done with the subsequent induction of
the mYME1L-variants expression and finally immunofluorescence (Fig.
3.9). Co-localization of the red fluorescent protein signal with the green
signal given by the immunodetected YME1L protein was observed for
all of the cell samples. Immunofluorescence also detects the endogenous
YME1L whose expression is by no means inhibited. However, lack of any
other specific signal pointing to the cytosolic or other localization suggests
that both endogenous and construct-derived protein is targeted into the
mitochondria.
Mitochondrial morphology upon overexpression of mYME1L variants
The knock down experiments have shown that functional iAAA pro-
tease is necessary for the maintenance of the mitochondrial network and
this role appears to operate through the proteolytic cleavage of OPA1.
Here, an effect on the mitochondrial morphology was observed upon
YME1L depletion which correlates with the disappearance of the long
forms of OPA1 (Fig. 3.4). To examine the effect of wild-type and mutant
mYME1L overexpression on mitochondrial morphology fluorescent mi-
croscopy was performed. The cells were transfected with the mitochon-
drially targeted red fluorescent protein (pDsRed-Mito) and grown in the
presence of tetracycline for 24h (Fig. 3.9, middle panel). No aberrations in
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Figure 3.9: YME1L localization and mitochondrial morphology of Flp-In™
T-REx™ expression cell lines
Clones confirmed for single FRT driven integration into the genome were transfected with pDsRed-Mito (Clon-
tech) fixed after 48 hrs post-transfection and incubated for overnight with the anti-YME1L antibody (ptglab,
1:50) and subsequently with FITC-conjugated goat anti-rabbit secondary antibody (1:1000). Mitochondrial lo-
calization of YME1L in control cells and expression cell lines can be seen by co-localization of the green signal
(YME1L) with red signal (pDsRed-Mito) in merged picture.
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the mitochondrial morphology were observed. This result indicates that
overexpression of wild-type or mutant variants mYME1L did not signifi-
cantly affect the mitochondrial network.
3.2.5 Functionality of the iAAA protease in the HEK293
cells expressing YME1L and YME1L
OPA1 processing at the S2 cleavage site
Given the wild-type mitochondrial morphology in the cells express-
ing mutant forms of mYME1L, OPA1 processing by the iAAA protease
was checked. It was demonstrated that OPA1 is cleaved proteolytically in
two sites: S1 and S2; where S2 is the one identified as the cleavage site
for YME1L protease [138]. Hence, transiently expression of OPA1 splice
variant 7 was done (sp7-OPA1). It is known to posses both of the sites,
and therefore processed to one long isoform L1 and two short isoforms
S4 and S5 [138]. S1 site was deleted from the constructed form giving
sp7-OPA1-∆S1 (Fig. 3.10). It resulted in the processing to only two forms:
long L1 and short S4. Additionally the construct was tagged C-terminally
with three Flag tags for detection independent of the endogenous OPA1.
In all of the cellular lysates processing of sp7-OPA1-∆S1 was unchanged
(Fig. 3.10). This result is in agreement with the mitochondrial morphology
observation, and suggests that iAAA protease is functional in all of the ex-
amined cells. An unequal loading of the protein samples is indicated by
the PS loading control. However in all of the samples two forms of OPA1
are detected corresponding to the long and short isoforms detected in the
wild-type HEK293 cell extracts. Different protein levels indicated by the
intensity of the bands detected by Western blotting could also result from
different transient transfection efficiencies.
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Figure 3.10: Processing of sp7-OPA1∆ S1 by various forms of mYME1L
HEK293 Flp-In™ T-REx™ control cells and expression cell lines with mYME1L wild-type (WT),
mYME1LK327A (WA), mYME1LE381Q (WB), mYME1LE542Q (EQ) and mYME1LE603Q (Ct) were transfected
with pCMV-sp7-OPA1∆S1-3Flag. 24h post-transfection expression of YME1L was induced for another 24h with
1 µg/ml of tetracycline. Total cell lysates were separated on SDS-PAGE and sp7-OPA1∆S1-3Flag processing at
S2 site was analyzed by immunoblotting with the anti-Flag antibody (Sigma). Ponceau S staining (PS) shown
in the lower panel serves as the loading control.
PNPase maturation
Yme1p in yeast was shown to be imported into the mitochondria via
TIM23 pathway, and its assembly into the proteolytically active complex
requires Tim54p belonging to the TIM22 translocon [72]. Hence, it was
proposed that Tim54p links mitochondrial import and turnover path-
ways. Interestingly, Yme1p itself was shown to have a role independent
of its proteolytic activity, in the mitochondrial translocation of an exoge-
nously expressed human PNPase through the inner membrane [122]. It ap-
pears therefore to be an important player in both mitochondrial turnover
and import and that those functions are carried out independently. The
proteolytic functionality of the overexpressed YME1L variants was con-
firmed by showing the cleavage of OPA1 at S2 site. However other,
non-proteolytic functions could be affected.
In the next experiment further YME1L function was assessed in HEK293
cells expressing mutant and WT forms of the protein. To check the matura-
tion of the endogenous PNPase, the YME1L expression was induced with
tetracycline (Fig. 3.11). All of the cells expressing mYME1L (WT, WA, WB,
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Figure 3.11: Overexpression neither of WT form of YME1L nor any of its
mutant affects PNPase
Whole cell lysates (WCL) and mitochondria (mt) isolated from clones expressing wild type (WT1, WT4)
or mutant murine YME1L variants: mYME1LK327A (WA), mYME1E381Q (WB), mYME1LE542Q (EQ) and
mYME1LE603Q (Ct) were subjected for SDS-PAGE and analyzed for PNPase by immunoblotting with hPNPase
specific antibody (Dr. C.Koehler). Yeast extracts from wild-type and ?yme1 strain expressing human PNPase
were used as controls. “m” indicates the mature form of PNPase.
EQ and Ct) were divided into two fractions. One fraction was subjected for
mitochondria isolation (mt). The second one was used for the preparation
of protein lysates from the whole cells (WCL). As the import of PNPase
into the mitochondria is coincident with its maturation, two forms of PN-
Pase in the wild-type control should be seen (Fig. 3.11; hPNPase expressed
in the yeast WT strain).And inhibition of the PNPase import should result
in aberrant forms, like those in the negative control (∆yme1 yeast strain
background). The wild-type and deletion control ∆yme1 are consistent
with the Rainey et al. report [122]. Whole cell lysates were checked together
with the mitochondrial extracts, in case the translocation is arrested and
PNPase resides in the cytosol. Still, our experiment showed the existence
of both precursor and mature forms of hPNPase, similar to the WT control,
and the expression of none of the mYME1L variants led to the band pat-
tern resembling ∆yme1 yeast control. Therefore, this indicates that iAAA
function in the protein translocation is not affected by the expression of
any of the mutant mYME1L proteins.
Assembly of the respiratory chain protein complexes
Mitochondrial function depends on the correct assembly of the respi-
ratory chain complexes and mitochondrial potential. In the following ex-
periments, other functions were examined, like respiration and ATP pro-
duction. For this purpose, first the assembly of the respiratory chain com-
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plexes was approached by Blue-Native PAGE (Fig. 3.12, [132]). Consistent
with the wild-type tubular mitochondrial network is the assembly of res-
piratory chain proteins which remained unaltered. That points to the un-
affected mitochondrial functionality in all of the clones.
Figure 3.12: Assembly of respiratory chain complexes
Mitochondria (200 µg) isolated from HEK293 Flp-In™ T-REx™ control cells and mYME1L expression cell lines
mYME1L wild-type (WT), mYME1LK327A (WA), mYME1LE381Q (WB), mYME1LE542Q (EQ) induced with
1 µg/ml of tetracycline for 24h were solubilized in 1% (w/v) DDM. Assembly of respiratory complexes was
examined by Blue-Native PAGE: samples were separated on the gradient 4-11% native gel and the complexes
visualized with Coomassie brilliant blue colloidal staining. Thioglobulin (669kDa) and apoferritin (443kDa)
serve as molecular mass references
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Discussion
Studies on the mitochondrial AAA membrane mAAA and iAAA pro-
teases revealed their conservation and close homology to the bacterial
FtsH. Experimental evidence indicated the mammalian subunits of both
mAAA and iAAA proteases as functional orthologs of the yeast pro-
teins. That revealed protein conservation from bacteria to high eukaryotes.
Both mAAA and iAAA protease complexes are involved in the mitochon-
drial quality control, degrading non-native proteins in the ATP-dependent
manner. Mutations in the mammalian mAAA protease subunits: paraple-
gin and AFG3L2 were identified in patients suffering of hereditary spastic
paraplegia (HSP) and OXPHOS impairment. The characteristic feature of
the mAAA-related HSP is an axonal decay in the motor neurons leading
to the lower limbs paralysis. Intensive studies are undertaken to reveal
the molecular mechanisms underlying those inheritable diseases. Close
homology of the human iAAA subunit YME1L to paraplegin led to specu-
lations about its involvement in pathogenesis of HSP. However, up to date
next to nothing is known about its function in the mammalian cells and
the molecular mechanisms it is involved in. Here with focus on the mam-
malian YME1L function in the mitochondrial proteolysis and morphology,
and approach them by knock down and the over expression studies.
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4.1 YME1L is specifically recognized by the an-
tibody and efficiently down regulated with
siRNAs
In vitro processing of the radiolabeled hYME1L by the MPP resulted
in the 60kDa protein. That is the size of a protein recognized by all of
three anti-YME1L antisera used in the present study. Immunoblotting re-
vealed mature form of the mammalian YME1L present both in human and
murine cells. With this method, no precursor form of the protein could be
detected. It should be ∼80 kDa in size. Furthermore, we could detect only
one isoform of the human YME1L, ∼60 kDa in size, in the human cell
lysates. This suggests that the annotated isoforms 1 and 3 are only forms
of the precursor protein, both efficiently maturated to the 60 kDa size.
Transfection with three different siRNAs resulted in the disappearance
of the 60kDa band, which was not the case in the negative transfection
control, both in MEF and HeLa cells. Taken together, we could specifically
recognize the mammalian YME1L protein with three different antibod-
ies, and efficiently and specifically down regulate the protein level using
siRNAs, both in murine and human cells.
4.2 YME1L is involved in the proteolysis of pro-
teins in the mammalian mitochondria
Destabilization of proteins leads to their degradation in the quality con-
trol process. In the case of the mitochondrial PHB1/PHB2 inner membrane
complex, depletion of PHB2 in mammalian cells is accompanied by the
loss of its assembly partner PHB1, with no loss of the Phb1 transcript [106].
As reported previously, both yeast prohibitins are substrates for proteol-
ysis by Yme1p upon destabilization of the prohibitin 1/prohibitin 2 com-
plex [75]. Here we report a proteolytic function of the mammalian YME1L
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in the degradation of PHB1, while its assembly partner PHB2 is depleted.
Our result shows, that the evolutionary conservation on the sequence level
- 42% homology between human and yeast Yme1p - is followed by the
functional conservation of the protein.
Proteolysis of unassembled protein complexes is one of the quality con-
trol functions. It allows removal of potentially dangerous proteins from
the mitochondria. Yme1p is the proteolytic subunit of the iAAA protease
which together with mAAA protease ensures the quality control in the
inner mitochondrial membrane, degrading non-native proteins. In yeast,
cells deleted in either mAAA or iAAA subunits reveal similar phenotypes
related to their respiratory incompetence, however the strength of those
phenotypes is different. ∆yme1 cells are only conditionally retarded in
growth, i.e. on the non-fermentable carbon source at 37°C and on glucose
at 14°C [23; 152]. Whereas YTA10 and YTA12 yeast mutants exhibit res-
piratory incompetence [62; 148] and lack of assembled respiratory chain
and ATP-synthase complexes in the inner membrane and can not grow
on a non-fermentable carbon source [54; 118; 158]. There were reports re-
vealing specific substrates of the yeast mAAA protease, but not for the
iAAA protease [112; 146]. Similarly, in the mammalian cells mutations in
the mAAA subunits are related to the mitochondria-related disorder, HSP
[24] which is related to the aberrant axonal development [101] and OX-
PHOS deficiencies [12]. Close homology between YME1L and paraplegin
and AFG3L2, both related to HSP, raised the speculations about the in-
volvement of YME1L in similar disorders [36]. Nevertheless, no mutations
in the Yme1l gene were identified in patients with OXPHOS deficiencies
[35]. It was suggested that both mAAA and iAAA proteases have an addi-
tional role in the regulation of mitochondrial dynamics and morphology,
independent of their proteolytic quality controlling in the mitochondria
and that those specific functions, rather than the common one which is the
proteolysis of unassembled membrane proteins in mitochondria, leads to
those differences.
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Interestingly, the further examination of the proteolytic function of
YME1L in mammalian cells revealed its involvement in the specific degra-
dation of TIM23. Thus, it is involved in the novel cell death pathway re-
ported recently [57]. The data show that the degradation of TIM23 accom-
plished by YME1L occurs upon apoptosis induction with the accompa-
nying inhibition of caspases. Therefore, it shares similarities with necrop-
tosis, which is also induced by the apoptotic stimulus with the simulta-
neous inhibition of caspases. However, the following organelle swelling,
plasma membrane permeabilization and lack of nuclear fragmentation
present in necroptosis point to the necrotic cell death [39]. Therefore,
TIM23-dependent cell death was proposed as an emergency pathway for
the apoptosis to occur under caspases inhibition [57]. In line with this, the
data demonstrate that TIM23 degradation was stronger with 50µM etopo-
side treatment for 48h, then 200µM etoposide for 24h, indicating that this
apoptotic pathway is rather late reacting. This would be in agreement with
the proposed “emergency pathway” theory, as in some tissues already
morphological changes occur within minutes after pro-apoptotic stimulus
[131; 149]. Down regulation of YME1L inhibits TIM23 degradation, and
thus cell death progress. Therefore, it might have therapeutic potential for
the diseases that involve caspase-independent cell death and result in loss
of irreplaceable cells, like neurons or cardiomyocytes.
4.3 Mammalian YME1L has a role in the mito-
chondrial morphology
OPA1 is present in the human cells in at least eight splice variants
which are proteolytically processed to two long isoforms (L1 and L2)
which can be further processed to three short isoforms (S3-S5) where S4
is a form that appears to be generated by YME1L [61; 73; 138]. Upon down
regulation of YME1L we could observe various aberrations in the mito-
chondrial morphology, which resemble aggregated and fragmented tubu-
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lar network. Such an effect was previously observed in yeast ∆yme1 cells
[23] therefore it further points to the conserved function of the mammalian
protein. Moreover, we observed induced cleavage of OPA1. It appears that
OPA1 is not degraded; rather the processing is induced, as long isoforms
disappear and the short ones accumulate. Such an accelerated process-
ing, however with an accompanying degradation is also observed upon
transmembrane potential dissipation [44]. Here, YME1L down regulation
did not result in the collapse of the membrane potential with neither of
used siRNAs. Hence, it suggests that in both cases different mechanism
are involved. This result is in agreement with the notion, that YME1L pro-
cesses OPA1 at the S2 site constitutively and in the potential-independent
manner, unlike PARL and mAAA protease, which require the mitochon-
drial potential [61; 73; 138]. Similarly, PHB2 depletion was shown to in-
duce the cleavage of OPA1 independent of the transmembrane potential
[106]. However, we observed that both PHB2 and YME1L down regula-
tion result in different mitochondrial phenotypes. Moreover, simultane-
ous depletion of both proteins results in the mitochondrial morphology
resembling the single PHB2 depletion. This indicates an epistatic effect
of PHB2 over YME1L. It suggests also involvement of both proteins in
different pathways of the mitochondrial morphology regulation. It is not
known, however, which way YME1L could function in the mitochondrial
fusion. We cannot exclude cristae remodeling, as YME1L cleaves OPA1.
However it would presumably involve different mechanism than PHB2.
Recently, F1F0-ATP synthase (also known as F1F0-ATPase) was shown to
be essential for the mitochondrial fusion, cristae formation and the main-
tenance of the tubular morphology [10; 56; 119; 139]. It is a rotary enzyme
reversibly synthesizing ATP in the coupled to the proton transport across
the membrane manner. F1F0-ATP synthase forms dimeric and oligomeric
supercomplexes. Yeast Mgm1p is required for the proper oligomerization
of F1F0-ATP synthase [5]. Yme1p was suggested to catalyze the turnover
of F1-ATPase protein inhibitors [42; 86; 93] and influence F1-ATPase func-
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tion and activity [48]. Hence, it is conceivable, that Yme1 protein could be
a link between F1F0-ATP synthase oligomerization or conformation and
Mgm1/OPA1, and as such could influence the mitochondrial morphology.
To verify that possibility the respiratory chain proteins assembly could
be addressed upon the YME1L depletion. However, destabilization of the
oligomerized F1F0-ATP synthase forms which led to the dissipation of the
transmembrane potential was demonstrated not to affect other mitochon-
drial features, like morphology, cristae formation, mtDNA stability, enzy-
matic activity of cytochrome c oxidase, maximal respiration rate and en-
zymatic activity of F1F0-ATP synthase [18]. It appears likely therefore, that
the activity of F1F0-ATP synthase and not its oligomeric state is important
for mitochondrial function. So far no evidence has been gathered for the
Yme1p - F1F0-ATPase direct or indirect interactions. Similarly, no clear ev-
idence could point out and explain the influence of Yme1 on the F1F0-ATP
synthase activity.
The double PHB2/YME1L depletion phenotype could also suggest
upstream function of PHB2 to YME1L. But in such a case, one might
see an effect of PHB2 down regulation on the level of YME1L, as both
proteins were functionally dependent. Here, PHB2 depletion did not affect
the YME1L steady-state level.
Summarizing, the present study could show that mammalian YME1L
is an evolutionary conserved protein with functions in the quality con-
trol, proteolysis and mitochondrial morphology. Moreover, YME1L was
demonstrated to specifically degrade TIM23 in the novel apoptotic event.
Hence, YME1L appears to be an important player in both cell survival
and cell death, having roles beyond its involvement in the proteolysis of
non-native proteins. The results further suggest that YME1L is not essen-
tial for the cell viability, as no increase in cell death was observed upon the
protein down regulation throughout the experiments. It is however note-
worthy, that the cellular survival was not assessed over the longer time
periods. Therefore, the long-term effects of the YME1L-absence remain an
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open question. Additionally, the dividing, immortalized cells were used
throughout the study, whereas the disorders YME1L was suggested to be
involved in, affect neurons - the irreplaceable, finally differentiated and
non-dividing cells. It is conceivable, that this kind of cells accumulate the
defects over time. Malfunctions of the mitochondrial fusion/fission ap-
paratus and lack of a fully functional proteolysis result in the decreased
quality control. This, in turn, could lead to the accumulation of mtDNA
mutations and reactive oxygen species (ROS) which would further dam-
age mitochondria. In the present work, the conserved function of YME1L
in the degradation of non-assembled prohibitin 1 was shown. Assuming,
that its role in the proteolytic turnover of the yeast Psd1p [108] is also con-
served in higher eukaryotes, its depletion might negatively influence the
mitophagy. Therefore, the damaged mitochondria would not be removed
efficiently, which might result in the induction of cell death. Decreased
proteolytic quality control could also lead to the accumulation of the mis-
folded or damaged proteins within mitochondria. Furthermore, the mito-
chondrial transmembrane potential could collapse as a result of mtDNA
mutations or deletions. This, in turn, might lead to the inhibition of the
mitochondrial import, inhibition of the cell growth and/or the induction
of apoptosis. The formation of intracellular and extracellular aggregates
of protein fibrils are common neuropathological features of many diverse,
neurodegenerative, progressive and late-onset disorders, such as sporadic
and familial Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral
sclerosis, and prion encephalopathies [157]. Therefore, to further investi-
gate YME1L function in the mitochondria, and learn about its relevance
for the cell on the organism level and over the time and development, an
animal deletion model might be generated.
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4.4 Overexpression of YME1L in the cells
In the next experiments, the iAAA function in the mammalian cells
was assessed by the expression of various forms of the murine YME1L.
The goal was to examine the effects of the YME1L dominant negative mu-
tant expression. Observations in our laboratory showed that the Walker B
motif mutation in the conserved glutamate residue of AFG3L2 has a dom-
inant negative effect on the mAAA protease (Ines Raschke and Dr Steffen
Augustin personal communication). Therefore, we investigated effects of
an expression of the similar mutant (mYME1LE381Q) together with muta-
tions in several other conserved residues (K327A, E542Q and E603Q).
Depletion of some mitochondrial inner membrane proteins was shown
to have an effect on the cell growth. For example, PHB2 deficiency led to
the inhibition of the cellular proliferation [106]. Similarly, degradation of
TIM23 resulted in the cell cycle inhibition and retardation of the cell prolif-
eration [57]. Expression of the dominant negative AFG3L2 mutant rapidly
inhibited proliferation and induced cell death (Ines Raschke personal com-
munication). Therefore, we examined effects of the YME1L expression as
a mutant or wild-type protein on the cell growth. Surprisingly, none of the
mutations led to the cell growth retardation. The possible reasons are that
either none of the mutant variants had a dominant negative effect on the
iAAA protease, or it had, but malfunctions of the iAAA complex did not
lead to the cell proliferation effects. Or the overexpressed proteins were
not correctly inserted into the mitochondria, and therefore had no effect on
the iAAA protease, and thus on the cellular growth. But given that iAAA
protease is not essential for the cell viability, it might be possible, that no
growth defects would be observed even if the iAAA protease was not fully
functional. Therefore next, the iAAA protease targeting and functionality
were approached upon overexpression of various forms of the mYME1L.
The cleavage of both C-terminal StepII tag and 8HIS tag from the over-
expressed proteins made it impossible to distinguish the exo- and endoge-
nously expressed forms. Nevertheless, the immunofluorescence detection
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revealed YME1L only in the mitochondria. No other signals were de-
tectable which could point to other than mitochondrial localization or pro-
tein aggregation in the cytosol. Hence, this indicates that both wild-type
and mutant variants of the mYME1L were efficiently targeted into the mi-
tochondria. Having excluded the possibility of a mistargeting, the func-
tionality of the mammalian iAAA protease was examined upon overex-
pression of different forms of mYME1L. The known roles of the mam-
malian YME1L were addressed.
The YME1L-dependent cleavage of OPA1 splice variant 7 at S2 site re-
sults in one long L1 and one short S4 isoform of OPA1. It was demon-
strated that beside YME1L, some other, so far not identified protease
cleaves OPA1 at this site [138]. Therefore upon YME1L depletion the long
L1 form accumulates, and the short one is still present, however in lower
amount [138]. Upon overexpression of mYME1L or mYME1L in HEK293
cells, the ratio of the long isoform to the short one did not change. The
conclusion is, that neither wild-type nor mutant variant of YME1L af-
fected proteolytic cleavage of OPA1 at the S2 site. Hence, the proteolytic
activity of the iAAA complex was not affected. In line with this result is
the wild-type tubular mitochondrial morphology visible in the examined
cells. It points to an unaffected function of YME1L in the mitochondrial
dynamics.
The morphology effect could be seen even with not complete deple-
tion of the protein, whereas mYME1LWT overexpression did not result in
changes in the mitochondrial morphology. It seems therefore, that the mor-
phology is more sensitive to the decrease, than the increase of the YME1L
level. It might be possible, that also here the level of the endogenous pro-
tein is sufficient to fulfill all of the iAAA protease functions. Farther ex-
pression of the protein might have no effect on the complex, independent
of its mutation. In this case, expression of those mutant forms in the null
background would shine a light on the mammalian iAAA protease func-
tion. This was addressed by down regulation of the endogenous protein
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by siRNA transient transfection with duplexes against the human YME1L.
It was then followed by the murine YME1L expression (data not shown).
No YME1L protein could be detected. Maybe the down regulation was as
efficient as to knock down the murine protein despite of sequence mis-
match between siRNA duplex and mRNA sequence? To exclude such a
possibility, down regulation has to be performed with a use of siRNAs de-
signed against the UTR fragment of mRNA, which is present only on the
endogenous and not vector-derived mRNA. Unfortunately, none of the
siRNAs used in the present study and shown to efficiently knock down
the protein, hybridizes within the UTRs.
In yeast, Yme1p was demonstrated to have a role in the import of
an exogenously expressed human PNPase [122]. It is the only known
non-proteolytic function of the iAAA protease. Therefore, PNPase matura-
tion was used to further assess functionality of the mammalian iAAA com-
plex. No aberrant forms of PNPase were detected in the extracts from cells
overexpressing YME1L variants, which could resemble those reported
previously in ∆yme1 cells [122]. Also here, iAAA protease function ap-
pears to be unaffected.
Mutations in the mammalian mAAA protease increase oxygen con-
sumption, and decrease the maximum respiration capacity which is be-
lieved to be related to the uncoupling of the electron flow from the ATP
production (Ines Raschke and Sarah Ehses personal communication). This
could be related to effects on the assembly of the respiratory chain com-
plexes. Following this line, the assembly of respiratory proteins was ap-
proached by the protein electrophoresis in native conditions. In none of the
cells expressing wild-type or mutant mYME1L the assembly of those pro-
teins was affected. It suggests functional respiratory chain, but does not
exclude decreased respiration capacity. To verify it further, oxygen con-
sumption and ATP production should be addressed.
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Taken together, the collected data indicate, that none of the chosen mu-
tations introduced into the mYME1L sequence, resulted in the dominant
negative effect on the iAAA proteolytic complex.
Mammalian subunit AFG3L2 was shown to homooligomerize [87].
It was related to the increased severity of the AFG3L2 mutation when
compared to paraplegin as paraplegin forms only heterooligomers with
AFG3L2 [101]. So far, YME1L is the only known subunit of the mammalian
iAAA complex. In yeast Yme1p was found in complexes with Mgr1p. It is
however a non-enzymatic subunit, therefore it was proposed to regulate
the function of the iAAA protease. In the case of mammalian iAAA no
co-factors are known to modulate its activity. No homologues of Mgr1
were identified in higher eukaryotes [42]. Therefore it is assumed that
only YME1L builds up the functional iAAA protease complex. Concluding
from the effects of AFG3L2 mutation, dominant effect was expected for
some of the mutations introduced into the sequence of mYME1L and
efficiently expressed in the HEK293 cells. Contrary to this, none of the
mutations inhibited the complex, nor resulted in any phenotypic effects,
despite of the efficient induction of the transgene expression detected by
the immunoblotting.
Then the question arises: is this possible, that YME1L is able to self -
process like FtsH [3] or its overexpression triggers degradation by some
not identified protease? Then, the increase of its concentration might re-
sult in the increased turnover of the protein by the endogenous YME1L
or some other protease. It seems that in such a case, the induction of
YME1L expression would not be detected in the extend detected here by
immunoblotting. However, to further address this possibility, chase exper-
iments should be designed to follow changes in the protein concentration
over time.
The results indicate that the overexpressed protein is imported into
the mitochondria. In parallel, the assembly of the iAAA protease was ap-
proached by protein electrophoresis in the native conditions (BN-PAGE).
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We could observe complexes similar to those in the wild-type HEK293
cells only in the case of mYME1LWT (Appendix 2, page 85). Their size is
in agreement with the reported size of the yeast iAAA complex which is
∼800 kDa [42]. In the cells expressing ATP-binding mutant mYME1LWA,
the size of the iAAA complex is shifted to bigger, as well as its assem-
bly seems to be more sensitive towards detergent treatment. (1% DDM
in all samples). Similarly, in the cells expressing ATP-hydrolysis mutant
mYME1LWB, the iAAA complex appears to be destabilized under the sol-
ubilization conditions used in the experiment, as a smear of not fully as-
sembled YME1L forms appear. In the cells expressing proteolyticaly inac-
tive mutant mYME1LEQ, the iAAA complex size is shifted towards bigger.
However, it seems to be stable in the used detergent concentration. This
suggests, that the assembly of the YME1L subunits into the complex is not
affected, and the bigger size of the complex might result from the trapping
of some interaction partner/substrate by the proteolyticaly inactive sub-
units. Taken together, assembly of YME1L in the cells expressing mutant
variants of the protein results in different than wild-type complexes. Are
they less stable, or better accessible for the detergent upon membrane sol-
ubilization, which would suggest less compact folding? Regardless of it,
YME1L protein oligomerizes into the complexes in the way, which allows
fulfilling all of the examined functions of the iAAA protease, giving no
phenotypic effect.
From the studies on the yeast and mammalian mAAA we know that
it forms hexameric rings in the inner membrane, similar to the structures
proposed for FtsH (Dr Steffen Augustin and Florian Gerdes personal com-
munication and [15; 90]). It has been proposed that the ATPase activity
of the AAA proteases is needed for the substrate unfolding and translo-
cation, but not the proteolysis itself. Conserved loop regions within the
central channel formed by the ATPase subunits have been demonstrated
to be involved in a substrate binding [70]. ATP-dependent conformational
changes of these loops are thought to drive the translocation and accom-
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panying unfolding of associated substrates into the proteolytic chamber
[58].
A mode of ATP hydrolysis proposed is a semi-sequential for yeast and
sequential for mammalian mAAA where binding of ATP to one subunit
blocks the ATP hydrolysis by the clockwise neighboring subunit. In such
a mode of ATP hydrolysis a substrate is unfolded and pulled into the pro-
teolytic chamber for proteolysis in an effective and coordinated manner. It
was proposed that only 4 ATP molecules are bound to the complex at the
same time, and ClpXP studies have shown that Walker B mutation of one
subunit decreased the activity of the other to 60%, but even 1 fully active
subunit in the hexameric complex could perform a substrate translocation
[69; 103].
There is no experimental support for the ATPase activity followed by
proteolysis mode of action for the iAAA protease, but the high homology
to the mAAA suggests also conservation of common mechanisms. How-
ever, the results in the present study suggest that there could be differ-
ences in the ATP-binding and hydrolysis as well as substrate transloca-
tion mechanisms between the mammalian mAAA and iAAA protease. It
could involve more independent mode of action for each subunit in the
iAAA complex. Provided that each of the subunits was able to bind and
hydrolyze ATP, and the block on ATP binding and/or hydrolysis by one of
the subunits did not block the neighboring one, the assembly of mutated
subunits would not influence the whole complex. In this hypothetical situ-
ation only the mutation of each subunit in the iAAA complex would result
in its complete inhibition.
Similar situation would occur when the ATP-binding and hydroly-
sis were semi-sequential, like in the yeast mAAA (Dr Steffen Augustin
personal communication). There, the active unit of the whole complex
is a dimer of Yta12p and Yta10p. Blocked ATP-hydrolysis by Yta12p
blocks its neighbouring Yta10 subunit, but not vice versa. In the case
of the mammalian iAAA complex, that would be presumably homod-
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imer of only YME1L protein. Therefore, no different specificities in ATP
or substrate binding between all of the subunits should occur. It would
be therefore hard to imagine that the ATP binding and hydrolysis were
semi-sequentional, unless some up to now unidentified co-subunits of the
mammalian iAAA protease existed. They could influence or regulate the
manner in which the whole complex worked.
The next question is, whether the incorporation of a maximum of four
non-functional subunits would still leave a functional dimer, which would
keep on binding and hydrolyzing the ATP, providing the energy essential
for the function of the iAAA complex? And furthermore, it is questionable
that the conformational changes of the pore loop would be still possible
with ATP molecules irreversibly bound to the complex.
In yeast, there is a certain threshold value for overexpression of the
Yme1 protein (Tanja Engmann personal communication). In the HEK293
cells expressing the YME1L variants a mixture of an endogenous and ex-
ogenous protein is present, however we cannot conclude about the stoi-
chiometry of both. Provided the similar threshold in the mammalian cells,
it would be possible that the level of the expressed YME1L variants is not
reaching the concentration needed to result in the inhibition of a whole
iAAA protease complex.
Summarizing, the present study demonstrated expression of several
forms of the murine YME1L which did not result in the identification of a
dominant negative protein mutant. Hence, those results open many ques-
tions with regard to the molecular mechanism of the YME1L function in
the mitochondria as well as long term effects of its knock-out. Further
studies are needed for an identification of interaction partners and pos-
sible regulators of the mammalian iAAA protease.
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Materials and methods
5.1 Materials
5.1.1 Bacterial, yeast and mammalian strains and cell lines
All the bacterial and yeast strains as well as cell lines are listed in Table
5.1
Table 5.1: Strains and cell lines used in the study
Organism Cell line/Strain Reference
Escherichia coli XL10 Gold Stratagene
XL1 Blue Tanja Engman
Saccharomyces cerevisiae WT + hPNPase Dr Carla Koehler
∆yme1 + hPNPase Dr Carla Koehler
Mus musculus Mouse Embryonic Fibroblasts/
C57BL/6
Dr Carsten Merkwirth
Homo sapiens Human Embryonic Kidney/Flp-In™
T-REx™ HEK293
Invitrogen
Human cervix cancer cell line/ HeLa Dr Gerrit Praefcke
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5.1.2 Oligonucleotides
The synthetic oligonucleotides used in this study are listed in Table 5.2.
siRNA duplexes used in protein knock down studies are listed in Table 5.3
Table 5.2: List of oligonucleotides used in the study
Name 5‘ Sequence 3‘
TL4024 CCA AAT ATG AGT TCC TGT GCC ACT CTT CCT CCC ATG
TL4023 CAT GGG AGG AAG AGT GGC ACA GGA ACT CAT ATT TGG
TL4022 GTA ATA TGC AAT AAT AGC ATG ACC AGA TTG ATG ATA GGC TGT TAT AG
TL4021 CTA TAA CAG CCT ATC ATC AAT CTG GTC ATG CTA TTA TTG CAT ATT AC
TL4020 CCA CCA ACA GAA TCT AAT TGA TCG ATG AAT ATA ACA CAA GGA G
TL4019 CTC CTT GTG TTA TAT TCA TCG ATC AAT TAG ATT CTG TTG GTG G
TL4018 GGC AAG AAG CGT CGC CCC TGT TCC TGG TGG
TL4017 CCA CCA GGA ACA GGG GCG ACG CTT CTT GCC
TL4001 CTG CAG CTA TCA GTG ATG GTG ATG GTG ATG GTG GTG AGT ACT TTT TTC GAA
CTG CGG GTG GCT CCA TCT CACT TCC AAT TTC TT
TL4000 GGA TCC GCC GCC ATG TTC TCC CTG TCG A
TL2677 ATA TTA CAC AAA GGA TGC AAT GCC
TL2676 GAG GCA TGA TTG TAG CTT TAT TAA TTG
TL2675 GCA GAC GAT CAA TCA GCT TCT TG
TL2674 CAT TGG GTT TGA AAC CAT CCA
TL2673 TTG ATT CTG CGG TAG ACC CTG
TL2672 ATG TTC AAA AGT GAC ATT TTT CAT CT
TL2671 GTA CAT TAC GTT CCT CTA GCT TGT ACA
TL2670 CGT AAT GTA CTG AAC ATA TCT AAG TGA CC
TL2637 CCG TCG ACT CAT CTC ACT TCC AAT TTC TTT CC
TL2636 CCG GAT CCA TGT TCT CCC TGT CGA GCA CT
TL2602 AAC AGC TAT GAC CAT GAT TAC GC
TL2601 AAT ACG ACT CAC TAT AGG GCG AAT
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Table 5.3: List of siRNA duplexes used in protein knock down studies
Name Description 5‘ Sequence 3‘
siRNA1 hYME1L TTA AGG CAT TAT CTA ATG CCT CTG G
siRNA2 hYME1L TTC GAT GGC AGA TTG GGT TTC TGG A
siRNA3 hYME1L TTT AGT TCA GAT AAT CCA AGG TCC C
siRNA4 mYME1L TTC AGT TCG ACC CTT CAC ATC TGG C
siRNA5 mYME1L ATC ACT GTA GGT CAT AAC TCC AAG C
siRNA6 mYME1L AAC AAT TTG AAT CTC TTT GGC ATC C
siRNAY mPHB2 ATT GAA CTT GGC CAC CAC ACT CTT G
siRNAZ mPHB2 ATT CGG TTC TGT GAT GTG GCG ATC G
5.1.3 Vectors and constructs
All the vectors and constructs used in this study are listed in table 5.4.
Table 5.4: List of plasmids used in the study
Plasmid Reference
pGEM® -T-Easy Promega
pcDNA™ 5/FRT/TO Invitrogen
pDsRed2-Mito Clontech
pcDNA5 FRT/TO-mYME1LWT -StepII-8HIS this study
pcDNA5 FRT/TO-mYME1LK327A-StrepII-8HIS this study
pcDNA5 FRT/TO-mYME1LE381Q-StrepII-8HIS this study
pcDNA5 FRT/TO-mYME1LE542Q-StrepII-8HIS this study
pcDNA5 FRT/TO-mYME1LE603Q-StrepII-8HIS this study
pCMV-sp7-OPA1™ ∆S1-3Flag [73] #1958
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5.1.4 Antibodies
The antibodies used in this work are listed in table 5.5.
Table 5.5: List of antibodies used in the study
Antibody Dilution Reference
α hYME1L 1:500 Dr Carla Koehler
α mYME1L 1:500 Proteintech Group, Inc. (pt-
glab)
α mYME1L (SPY531) 1:250 -
1:500
this study
α TIM23 1:1000 BD Biosciences
α BAP37 (PHB2) 1:500 BioLegend
α prohibitin (PHB1) 1:500 NeoMarkers
α β-actin 1:5000 Sigma, clone AC15
α complexII, 70kDa 1:1000 Molecular Probes
α complexV, su α 1:1000 Molecular Probes
α COX2 1:1000 Molecular Probes
α OPA1 1:500 BD Biosciences
α FLAG M2 1:1000 Sigma
α PNPase 1:1000 Dr Carla Kohler
Goat anti-rabbit IgG HRP - la-
beled secondary antibody
1:10000 BioRad
Goat anti-mouse IgG HRP -
labeled secondary antibody
1:10000 BioRad
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5.1.5 General reagents
All laboratory chemicals used in the present study were purchased
either from Sigma or Merck unless stated otherwise. Enzymes used in this
study were purchased from NEB or Invitrogen with stated exceptions.
5.2 Methods
Standard methods of molecular biology were performed according to
established protocols [128].
5.2.1 Affinity purification of antisera
Rabbit SPY531 was immunized by the simultaneous injection of 2
peptides: EP071347 and EP071348. YME1L specific IgGs were purified
from serum by immunoabsorption on a peptide-conjugated Sulfo-Link®
(PIERCE) matrix.
Peptide coupling to the matrix
Peptides EP071347 (H2N - TLKSRTRRLQSTSER - CONH2) and EP-
071348 (H2N - DKILMGPERRSVEID - CONH2) used for the immuniza-
tion of rabbits and raising the polyclonal antibody against YME1L were
synthesized and supplied by the Eurogentec company. For the purifica-
tion, a SulfoLink® Coupling Gel (Pierce) matrix was used according to the
manufacturer‘s protocol. 1.5 mg of each peptide was dissolved in 50µl of
coupling buffer. The volume was slowly increased to obtain completely
dissolved peptides. The total volume of the pooled peptides solution was
adjusted to 3 ml. For each ml of peptide solution 1 ml of SulfoLink® gel
was used, i.e. the total column volume was 3 ml. Coupling efficiency was
calculated by the comparison of A280 nm of the non-coupled fraction (flow
through) to the starting sample and was ∼88%.
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Immunoabsorption of the antiserum
The matrix, conjugated with peptide, was equilibrated by consecutive
washings with 10 ml of 10 mM Tris-HCl, pH 7,5; 100 mM glycine-HCl, pH
2,5; 10 mM Tris-HCl, pH 8,8; 100mM Na-phosphate, pH 11,5; and 10 mM
Tris-HCl, pH 7,5. After the last washing step antiserum, diluted in buffer
B to a ratio of 1:1 and a final volume of 10 ml, was applied on the column
at a flow rate of 0,1 ml/min. This was repeated three times. The column
was then washed with 10 ml Tris-HCl pH 7,5, followed by a washing step
with 10 ml buffer C. Peptide specific IgGs were eluted in three steps.
Table 5.6: Buffers used in the antiserum purification
Buffer Composition
Coupling buffer 50 mM Tris-HCl, 5 mM
EDTA-Na pH 8.5
Buffer B 10 mM Tris-HCl, 1 mM PMSF, 1
mM EDTA, 2 mM EGTA, com-
plete protease inhibitor
Buffer C 10 mM Tris-HCl, 500 mM NaCl
pH 7,5
1. Elution with 10 ml 100 mM Na-citrate, pH 4,5. Elution fractions (1
ml) were collected and pH was adjusted to 7,0 with 1M Tris-HCl, pH
8,8.
2. Elution with 10 ml 100 mM glycine-HCl, pH 2,5. 1 ml fractions were
collected and the pH was adjusted to 7,0 with 1M Tris-HCl, pH 8,8.
The column was washed with 10 ml 10 mM Tris-HCl, pH 8,8.
3. Elution with 100 mM Na-phosphate buffer, pH 11,5. Fractions (1 ml)
were collected and the pH was adjusted to 7,0 with 1M glycine-HCl,
pH 2,5.
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The elution fractions were examined for the presence of IgGs by SDS-PAGE
and immunoblotting with HRP-conjugated secondary antibodies. Elution
fractions containing the majority of IgGs, were pooled and concentrated to
a volume of ∼500 µl with Centricon YM-100 (Millipore) centrifugal filter
concentrator according to manufacturer’s recommendations.
5.2.2 Cell culture
Growth conditions
Mouse embryonic fibroblasts (MEFs) and HeLa cells were cultured
in Dulbecco’s Modified Eagle’s (DMEM) GlutaMax™ -I medium (Gibco)
supplemented with 10% FCS, 1x non-essential amino acids, 1 mM sodium
pyruvate, and 1x penicillin/streptomycin. All the cells were kept at 37°C
99% humidity and 5% CO2. Flp-In™ T-REx™ HEK293 cells were main-
tained in Dulbecco‘s Modified Eagle‘s (DMEM) Gluta-Max™ -I (Gibco)
medium supplemented as above, with additional 15 µg/ml blasticidine
and 100 µg/ml zeocine. Cells were maintained in culture by growing them
until ∼80% confluency and passing in 1:50 dilutions (for MEFs) to 1:3 di-
lutions (for HEK293). For wild-type cell lines as well as for the stable cell
lines HEK293 Flp-In™ T-REx™ clones liquid nitrogen frozen stocks were
prepared.
Passing and freezing the cells
Cells grown to the desired confluency were washed twice with 1x
PBS. After complete removal of the PBS, 1x trypsin solution in PBS (PAA
Laboratories GmbH) was added and cell were incubated as follows: MEF
and HeLa cells 5 min in the standard growth conditions, HEK293 cells
not more than 3 min at room temperature. After the incubation, fresh
growth medium was added, at least the same volume as the previously
added trypsin. Cell suspension was pipeted up and down against the cell
bottom 5-8 times and put into a fresh falcon tube. Cells were pelleted
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down for 5 min, 1200 rpm, at room temperature. Liquid was removed and
the cell pellet was then loosened by hitting the tube bottom a few times.
Cells were passed by the addition of fresh growth medium and plating
onto fresh dishes in the desired dilutions. For freezing, the cell pellet
was resuspended in 10% DMSO in FBS and 1ml aliquots in cryo-tubes
were prepared and put on ice. For slow freezing, isopropanol-containing
freezing boxes were used. Tubes containing cells were put into the -80°C
freezer and transferred to liquid nitrogen storage after 24-72h.
5.2.3 Transfection
siRNA transfection
All siRNA transfections were done twice in 6-well plate format with
6-8 hours incubation in between. For YME1L down regulation with RNAi
murine - mRNA - sequence and human - mRNA - sequence - specific
Stealth RNAi (Invitrogen) were purchased (listed in Table. 5.3) together
with the Stealth RNAi Negative Control Duplexes. During the transfec-
tion no antibiotics were added to the medium, and Opti - MEM™ serum
reduced medium (Gibco) was used. After the second transfection cells
were incubated in the normal growth conditions for over night. siRNA
transfections were performed using the Lipofectamine RNAiMax reagent
(Invitrogen) according to the manufacturer’s protocols. For single siRNA
transfection 30 pmol of the siRNA duplexes [20 pmol/µl] per well were
added; in double siRNA transfections the amount was doubled per well,
taking 30 pmol of each siRNA duplex.
Plasmid transfection
Plasmids were transfected twice in the 6-well format with the Gene
Juice reagent (Novagen) following the manufacturer’s instructions, with
4-6 hours incubation in between and with 1µg of total plasmid DNA
per well. After the second time, cells were incubated over night under
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standard growth conditions. During the transfection DMEM GlutaMax™-
I medium supplied with 1x penicillin/streptomycin and OPTI -MEM™
medium were used.
5.2.4 Protein isolation from tissue culture cells
Growth medium was removed from the cells and they were washed
twice with 1x PBS which was then removed completely from the dish.
Ice-cold 1x PBS was added to the cells and they were detached from the
plates with a cell scraper and transferred into a cooled tube. No trypsin
treatment was ever used to avoid unspecific protein degradation. The
plate was washed again with fresh ice-cold PBS and the suspension was
transferred into the same tube. Cells were pelleted by centrifugation: 5
min, 800 x g at 4°C , and snap-frozen in the liquid nitrogen. The pellet
was resuspended in the lysis buffer and rotated for 2-3 hours at 4°C . Cell
lysates were cleared by centrifugation: 10 min, at 13000 rpm at 4°C; and
transferred into fresh tubes. Protein concentration was determined by the
Bradford protocol [22].
5.2.5 SDS-PAGE and Western Blotting
Sodium-dodecyl-sulfate polyacrylamide gel electrophoresis (SDS-PA-
GE) and semi-dry western blotting were carried out as described previ-
ously [91; 128]. Buffers and reagents used are listed in Table 5.7, page 68.
The transfer was done with the use of PVDF membranes for overnight at
room temperature. The BioRad mini-gel system was used.
5.2.6 Fluorescence microscopy
Cells were seeded on 6-well plates with cover slides. Dilutions de-
pended on the examined cell line to reach the density proper for trans-
fection reagents recommended by the manufacturers. To address the mi-
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Table 5.7: Buffers and reagents used in SDS-PAGE and immunoblotting
Buffer Composition
10xSDS running buffer 10 g/l SDS, 30,3 g/l Tris, 144,1
g/l glycine
10 x PBS 80 g/l NaCl, 2 g/l KCl, 26,8
g/l Na2HPO4-7H2O, 2,4 g/l
KH2PO4, pH 7,4 adjusted with
HCl
Blotting buffer 0,2 l/l methanol, 0,2 g/l SDS,
2,42 g/l Tris, 11,3 g/l glycine
PonceauS solution 100 ml 2 g PonceauS, 30 g
trichloroacetic acid, 30 g sulfos-
alicylic acid
10 x TBS 12 g/l Tris, 90 g/l NaCl, pH 7,4
adjusted with HCl
SDS-PAGE sample buffer 50 mM Tris/HCl, pH 6,8,
1% (v/v) β-mercaptoethanol,
2% (w/v) SDS, 0,01% (w/v)
bromphenol blue, 10% (w/v)
glycerol
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tochondrial morphology in siRNA down regulation studies transfection
was performed as follows: 2 times siRNA transfection with Lipofectamine
RNAiMax and 2 times pDsRed-Mito transfection with Gene Juice in 4 hour
intervals with the last transfection incubation lasting over night. The com-
plexes were removed and full growth medium was added. Otherwise,
only pDsRed-Mito transfection was performed according to the plasmid
transfection protocol (see page 66). Cells were subjected to lysis and/or
microscopy after 48h after the second plasmid transfection. Mitochon-
drial morphology was analyzed using the DeltaVision microscope system
equipped with Softworx software (Applied Precision).
5.2.7 Transmembrane potential detection
For transmembrane potential detection JC1 (Molecular Probes) stain-
ing was performed. HeLa cells were transfected with siRNA1 and siRNA2
as well as the scrambled negative control (Invitrogen). Untransfected
HeLa cells were used as a reference control. Cells were washed with 1x
PBS and detached from the dishes with a scraper. The cellular suspension
was transferred into a 1.5 ml tube, a small sample was used for calculation
of the cell number and approximately 2 x 105 cells were then pelleted by
centrifugation at 4°C, 800 x g, 5 min. and resuspended in 500 µl of growth
medium. To the control tubes 1 µl of 50 mM CCCP in DMSO was added,
to the other only 1 µl of DMSO and 15 min. of incubation at 37°C followed.
JC1 fluorescent dye was added to the final concentration of 2µM to CCCP
or DMSO treated or untreated samples, that were vortexed vigorously and
incubated at 37°C for further 15 min. Cells were pelleted by centrifugation
again, washed twice with 1xPBS and resuspended in 300 µl of 1xPBS. Flu-
orescence activated cell sorting (FACS) analysis at 590 nm followed. Sam-
ples were analyzed on a FACS Calibur equipped with CellQuest software
(Becton Dickinson).
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5.2.8 Cloning procedures
Competent cells
Competent Escherichia coli XL10 Gold or XL1 Blue were prepared as
follows: 3 ml LB medium was inoculated with the E.coli strain and incu-
bated overnight at 37°C . The whole culture was diluted into the 500 ml
of SOB++ or LB medium and incubated at 25-30°C until the measured ab-
sorbance of A600 reached 0.4-0.6, then it was chilled on ice for at least 10
min. The cells were spun down for 10 min, with 1500 x g, at 4°C and gently
resuspended in fresh 100 ml ice-cold TB buffer. The suspension was kept
on ice for the next 10 min, and a second centrifugation followed. The pellet
was then resuspended in 18.6 ml of ice-cold TB buffer and 1.4 ml of DMSO
was added. After this, the whole cell suspension was incubated on wet ice
for at least 10 min, and was aliquoted as 600µl per each, chilled on ice. The
aliquots were frozen in liquid nitrogen and stored at -80°C .
Table 5.8: Reagents for the preparation of competent E.coli cells
Buffer/medium Composition
TB buffer 10 mM HEPES pH 6.7, 15 mM
CaCl2, 55mM MnCl2, 250mM
KCl
SOB++ medium 20g/L bacto-tryptone, 5g/L
yeast extract, 0.5g/L NaCl,
0.186g/L KCl, 10 mM MgCl2, 10
mM MgSO4, (sterile MgCl2 and
MgSO4 have to be added just
before use)
LB medium 20g/L bacto-tryptone, 5g/L
yeast extract, 5g/L NaCl
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Transformation of bacteria
1 µl plasmid DNA (1ng/µl) was mixed gently with 100-200 µl of com-
petent cells. Cells were incubated at 0°C for 15-30 min and transferred to
heat-block for 90s heat shock at 42°C . They were cooled down on ice for
2 min and 1 ml LB medium without antibiotics was added. The tube lid
was punched with a needle and cells were incubated at 37°C , for 30-60
min, at 800 rpm shaking. Cells were spun down for 10s, resuspended in
100 µl of the LB medium and plated on LB agar plates with according an-
tibiotics. Plasmid DNA was isolated from the E.coli cells with an alkaline
lysis method [16] and with NucleoSpin™ columns (Machery & Nagel) fol-
lowing the supplier’s instructions. DNA ligations were performed using
DNA T4 Ligase (NEB) following the manufacture’s prescriptions.
DNA sequencing
Plasmids or DNA fragments were sequenced with the ABI Big Dye
Terminator Sequencing Kit (Applied Biosystems) according to established
methods [129]. The fluorescently labeled DNA fragments were analyzed
with an ABI Prism 3730 DNA analyzer (Applied Biosystems).
5.2.9 Preparation of the mYME1L-StrepII-8HIS expression
constructs
For expression of the full length murine YME1L and its mutants,
C-terminally tagged with a StepII-8HIS double tag in the Tet-inducible
T-REx™ Flp-In™ (Invitrogen) system in the mammalian HEK293 cells,
High Fidelity PCR (Roche) was performed with TL4000/TL4001 primers
(Table 5.2, page 60), supplied with 2%DMSO for higher PCR efficiency. The
product was subcloned into pGEM-T Easy (Promega) and positive clones
were confirmed by sequencing with TL2601/2602 and TL2670-2677 pairs
of primers Table 5.2). Mutagenesis was done with the Quick Change® XL
Site-Directed Mutagenesis Kit (Stratagene) with the following primers:
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• mYME1LK327A: TL4017/4018;
• mYME1LE381Q: TL4019/4020;
• mYME1LE542Q: TL4021/4022;
• mYME1LE603Q: TL4023/4024.
When the mutation regions were sequenced and confirmed, YME1L--
StrepII-8HIS and YME1L-StrepII-8HIS were cloned into
pcDNA™ 5/FRT/TO (Invitrogen) with NotI sites. The correct insertion
was checked by a HindIII digest.
Generation of stable Flp-In™ T-REx™ HEK293 cell lines expressing
mYME1L-StrepII-8HIS and mYME1L-StrepII-8HIS
For stable cell lines Flp-In™ T-REx™ HEK293 cells were transfected
with 3 µg of the total plasmid DNA per well in a 6-well plate in the ratio
of 1x pOG44 : 5x pcDNA5FRT/TOmYME1L construct (listed in Table. 5.4).
Transfection mixture was removed after over night incubation and fresh
growth medium was poured onto the cells. After 48 hours hygromycin B
(150 µg/ml) was added to the cells for selection. Visible clones were picked
after another 10 days; 100 clones for each transfected construct. Genomic
integration was checked by β-galactosidase staining followed by immun-
odetection of the YME1L and YME1L protein in the cell lysates from
non-tetracycline-induced cells versus 1µg/ml Tetracycline-induced for 24
hours cells. Clones were cultured in DMEM Gluta-Max™ -I medium sup-
plied with 10 µg/ml of blasticidine, 50 µg/ml of hygromycin B, 1x peni-
cillin/ streptomycin and 7.5% Tetracycline-Reduced Fetal Bovine Serum
(Biochrom AG) for keeping the expression repressed. Growing conditions:
5% CO2, 99% humidity, 37°C .
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β-galactosidase activity test
Growth medium was removed from HEK293 T-REx Flp-In™ cells and
they were washed once with 1x PBS and fixed with 0.2% glutaraldehyde/
2% formaldehyde/ PBS solution for 15 min. at 4°C . After double washing
with 1x PBS, β-gal Staining Buffer (1 mg/ml X-Gal, 5 mM K3Fe(CN)6, 5
mM K4Fe(CN)6, 2 mM MgCl2, 0.02% NP-40, 0.01% SDS) was added to the
cells and they were incubated at 37°C for 1 hour, washed with 1x PBS twice
and pictures were taken.
Immunofluorescence of the HEK293 Flp-In™ T-REx™ clones
Cells were grown in 6-well plates on the cover slides treated with 0.1%
poly-lysine solution (w/v) for better adhesion. After two washings with
1x PBS cells were fixed with 3% para-formaldehyde solution in PBS for 20
min at the room temperature. Subsequently they were washed twice with
1x PBS and permeabilized with 0.15% Triton X-100 solution in PBS for 15
min at room temperature. Blocking solution [2% BSA in PBS] was added
to the cells for 1h, removed and the primary antibody was added: 100 µl of
antiYME1L antibody (ptglab) 1:50 in 2% BSA/PBS. Overnight incubation
in the humid and dark chambers at 4°C followed. The primary antibody
was washed away with the blocking buffer 3 x 10 min. Then the Alexa
Fluor 488 dye-conjugated goat anti-rabbit secondary antibody (Molecular
Probes) was added (1:1000 in 3% BSA/PBS with 1 µg/ml DAPI) for 2h
at room temperature. Again, 3 x 10 min. washing steps followed. Cover
slides were mounted with ProLong® Antifade (Invitrogen) and sealed
with a transparent nail polish.
5.2.10 Isolation of mitochondria from tissue cultures
Cells were grown in the standard conditions to ∼95% confluency. To
avoid unspecific degradation of the cellular proteins no trypsin was used.
Cells were washed with 1x PBS, detached form the plates with cell scrap-
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ers and resuspended. The isolation of mitochondria was performed ac-
cording to the previously described method [50]. Protein concentration
was determined by the Bradford method [22].
5.2.11 Blue-Native polyacrylamide gel electrophoresis
The gradient gels used in this study were composed of a separation
gel with a linear gradient of 3-11% polyacrylamide prepared as follows:
Equal volumes of 3% and 11% gel solutions were prepared and poured
into the BioRad mini-gel system plates using the gradient maker. Gels
were left for polymerization at 4°C , for at least 3h. Mitochondria (200
µg) were resuspended in the solubilization buffer supplemented with 1%
dodecyl-maltoside (DDM) by pipeting and kept on ice without shaking
for 30 min. Final protein concentration was 2µg/µl. The non solubilized
material was spun down: 30 min, 4°C , and 30000 x g. The supernatant
was transferred into a fresh tube and supplemented with CBB buffer and
glycerol (10% final concentration). The electrophoretic separation was car-
ried out in Mini-Protean-3-gel chambers (Bio-Rad) at 4°C with deep blue
cathode buffer, using a constant voltage of 50V and a current of 15 mA
for ∼30 min, followed by 300V and 15 mA for ∼30 min. Subsequently, the
deep blue cathode buffer was exchanged for a cathode buffer of identical
composition but lacking Coomassie blue G-250 (colorless cathode buffer)
and the separation was continued at 300V and 15mA. Thioglobulin (669
kDa) and apoferritin (443 kDa) were used for calibration. Protein com-
plexes were detected by a Commassie Coloidal Blue stain for overnight
followed by destaining in Millipore water.
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Table 5.9: Buffers used in BN-PAGE
Buffer Composition
3x gel buffer 75mM Imidazole/HCl pH 7.0, 1.5M
6-aminohexanoic acid
Acrylamide /
bis-acrylamide
mix
48% acrylamide, 1.5% bis-acrylamide
Blue-Native sam-
ple buffer (CBB)
1% Coomassie® Brilliant Blue G250 in
solubilization buffer
Solubilization
buffer
30mM Tris/HCl pH 7.4, 50mM
NaCl, 4mM Mg-Acetate, 5mM
6-aminohexanoic acid, 1mM ATP,
1mM PMSF, 1x Complete® protease
inhibitor (Roche)
Anode buffer 25mM Imidazole/ HCl pH 7.0
Colorless cathode
buffer
50mM Tricine, 7.5mM Imidazole
Deep blue cathode
buffer
50mM Tricine, 7.5mM Imidazole,
0.02% Coomassie® Brilliant Blue
G250 (SERVA)
3% gel solution 3% acrylamide/0.09%
bis-acrylamide, 1x gel buffer, 2%
glycerol, 0.003% APS, 0.0003%
TEMED
11% gel solution 11% acrylamide/0.35%, 1x gel buffer,
30% glycerol, 0.003% APS, 0.0003%
TEMED
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List of abbreviations
• AAA - ATPases associated with a variety of cellular activities
• APS - ammoniumperoxo disulfate
• ATP - adenosine triphosphate
• bp - base pairs
• CCCP - carbonyl cyanide m-chlorophenylhydrazone
• cDNA - complementary DNA
• C-terminal - carboxyterminal
• C-terminus - carboxy terminus
• DMSO - dimethyl sulfoxide
• DNA - deoxyribonucleic acid
• EDTA - ethylene diamine tetraacetic acid
• Fig. - Figure
• g - standard gravity
• GTP - guanosine triphosphate
76
Chapter 6. List of abbreviations
• h - hour(s)
• HCl - hydrochloric acid
• HEPES - N-2-hydroxyethylpiperazine-N?-2-ethanesulfonic-acid
• HSP - hereditary spastic paraplegia
• K - potassium
• kb - kilobase pairs
• KCl - potassium chloride
• kDa - kilodalton
• KOH - potassium hydroxide
• m - meter
• M - molarity (mole per liter)
• MDa - megadalton
• MEF - mouse embryonic fibroblast
• µg - microgram
• µl - microliter
• mg - milligram
• ml - milliliter
• Mg - magnesium
• min - minute(s)
• mM - millimolar
• mRNA - messenger RNA
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• MPP - mitochondrial processing peptidase
• mt - mitochondrial
• mtDNA - mitochondrial DNA
• MTS - mitochondrial targeting sequence
• NaCl - sodium chloride
• NADH - nicotinamide adenine dinucleotide (reduced form)
• NaOH - sodium hydroxide
• NP-40 - Nonidet P-40
• N-terminal - aminoterminal
• N-terminus - amino terminus
• OXPHOS - oxidative phosphorylation
• PAGE - polyacrylamide gel electrophoresis
• PBS - phosphate buffered saline
• PCR - polymerase chain reaction
• PMSF - phenylmethylsulphonyl fluoride
• RNA - ribonucleic acid
• RNAi - RNA interference
• ROS - reactive oxygen species
• rpm - rounds per minute
• RT - room temperature
• s - second(s)
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• SDS - sodium dodecyl sulfate
• SPG - spastic paraplegia gene
• SRH - second region of homology
• TBS - Tris buffered saline
• TCA - trichloracetic acid
• TEMED - N,N,N’,N’-Tetramethylethylenediamine
• TIM - translocase of the inner membrane
• TM - transmembrane domain
• TOM - translocase of the outer membrane
• Tris - 2-amino-2-(hydroxymethyl)-1,3-propandiole
• U - unit(s)
• UPS - ubiquitin-proteasome system
• v/v - volume per volume
• V - volt
• wt - wild-type
• w/v - weight per volume
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A multisequence alignment of AAA protease subunits from bacteria,
plant, yeast, mouse, rat and human is presented on Fig. 1, 2, 3 pages 82,
83, 84.
Alignment was done using the multisequence alignment software AlignX
with default setting and visualized with GeneDoc. Sequences were ex-
tracted from the national center for biotechnology information (NCBI).
The color code used in alignment is presented in the table below.
Table 1:
Residues Foreground/Background
non similar black/white
conservative grey/black
block of similar black/grey
identical white/black
weakly similar green/white
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Figure 2: Continued from page 82 multisequence alignment of AAA pro-
tease subunits from bacteria, plant, yeast, mouse, rat and human
83
Figure 3: Continued from page 83 multisequence alignment of AAA pro-
tease subunits from bacteria, plant, yeast, mouse, rat and human
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Figure 4: Assembly of the iAAA protease complexes
Mitochondria (200 µg) isolated from HEK293 Flp-In™ T-REx cells™ (lane 1) and mYME1L expression cell lines:
mYME1L wild-type (WT, lane 2), mYME1LK327A (WA, lane 3), mYME1LE381Q (WB, lane 4), mYME1LE542Q
(EQ, lane 5), induced with 1 µg/ml of tetracycline for 24h were solubilized in 1% (w/v) DDM. Assembly
of the YME1L into complexes was examined by Blue-Native PAGE: samples were separated on the gradient
4-11% native gel and blotted onto PVDF membrane for overnight at room temperature. Complexes were
immunodetected with the specific anti-YME1L antibody (ptglab, 1:500). Thioglobulin (669kDa) and apoferritin
(443kDa) serve as molecular mass references.
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